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ABSTRACT
The present study is based on the finding that 
treatment with the new anticancer drug, ICRF 159, 
completely inhibited the formation of métastasés in 
mice implanted with the Lewis lung carcinoma (3LL), at 
doses which had little effect on the growth rate of the 
primary tumour. The mode of action of the drug 
appeared to be on the development of the blood vessels 
of the primary tumour.
Studies were carried out to demonstrate the nature 
of the changes occurring in the structure and function 
of tumour blood vessels brought about by treatment with 
ICRF 159. X-ray angiography, carbon black (Pelikan ink) 
labelling and intravital staining with lissamine green 
have demonstrated that many of the characteristics of 
tumour blood vessels were absent in tumours treated with 
ICRF 159, Further, the blood vessels of treated tumours 
were relatively normal in structure and arrangement.
Any alteration of the morphology of tumour blood 
vessels may affect the rate of blood flow through the 
tumour. As this could be critical for most therapeutic 
modalities, the rate of blood flow through 3LL tumours 
treated with ICRF 159 was measured but was found not to 
be significantly different from control values.
It has been reported that tumour blood vessels are 
abnormally sensitive to serotonin at doses which have 
little effect on the blood vessels of normal tissue.
Although control 3LL tumours demonstrated a marked 
response to serotonin, no such effect was shown in 
tumours treated with ICRF 159.
Finally, it was demonstrated that ICRF 159 did 
not alter the viability of 3LL cells found in areas 
of the tumour which were devoid of functional blood 
vessels. These cells were capable of propagating 
the growth of new tumours.
The profound modification of the morphology and 
functional character of tumour blood vessels brought 
about by treatment with ICRF 159, termed 
"angiometamorphic”, could be of considerable 
importance in the treatment of primary and secondary 
tumours.
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SECTION I
General Introduction
8Bergel (1970) stated, "The medical profession 
is almost powerless against the dissemination of 
malignant cells, leading to métastasés or secondary 
deposits. This statement does not exclude short­
term control of such growths by ionising radiation, 
adrenalectomy, other surgical interference with 
hormonally controlled organs or by chemotherapy of 
tumours of childhood. But on the whole, as the 
number of such favourable cases is relatively few, 
the problem of fighting métastasés is one of the most 
urgent. The reason for this, well know to clinicians, 
is that although not infrequently primaries can be 
successfully attacked, the patient may succumb to the 
highly resistant secondaries?.
It is well known that where cancer is diagnosed 
in its early stages, present day'forms of therapy 
can prove highly effective. Unfortunately, where 
dissemination has taken place, surgery and radio­
therapy can to a large extent be only palliative. It 
may be that chemotherapy will provide a potential 
remedy against the spread of cancer.
Dissemination of tumour cells by vascular channels 
and the establishment of distant métastasés occurs 
during some stage in the natural history of many 
malignant tumours. Although most of the 
haematogenously spread cancer cells are probably 
destroyed within the confines of the blood vessels, the 
fact that 80% of terminal cancer patients have métastasés 
in other organs suggests that some of the disseminated 
cancer cells,do, in fact, survive and proliferate 
(Roberts, 1961, Hellmann, 1971).
Tumour cell dissemination may be considered 
as occurring in four distinct phases:
1. Invasion of cancer cells into vascular 
channels or lymphatics.
2. Transportation from the primary tumour of 
single tumour cells or clumps of cells in 
the blood stream to distant parts of the 
body.
3. Implantation of the tumour cells in the 
arterioles and capillaries of the distant 
organs.
4. Growth of the secondary deposits.
Accordingly, any measures to prevent dissemination 
via the circulation should be aimed at preventing the 
invasion of tumour cells into the vascular channels 
(stage 1), as this would localise the neoplasm and 
facilitate therapy. The advantages of finding a 
suitable experimental model for studying the 
haematogenous spread of métastasés are obvious, in 
that compounds could be tested specifically for 
inhibitory effects on tumour dissemination, but, the 
main problem for many years has been the discovery 
of such a test system.
Many workers have bypassed the problem by 
injecting tumour cells intravenously,but this expedient 
is not entirely satisfactory since important early 
stages in the process of metastatic spread are 
therefore also bypassed, i.e. the invasion and release 
of cancer cells into vascular channels. The assumption
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that injected cells from a tumour mash are equivalent to 
malignant cells leaving a primary tumour cannot be 
justified.
The first attempts to investigate the mechanism of 
tumour dissemination were made by Levin and Sittenfield 
(1911), studying a number of rat sarcomas and carcinomas. 
However, it was not until the work of Ketcham e_t ^  (1966); 
Karrer ^  al (1967) and Wexler ^  al (1969), that an 
experimental tumour was described which metastasised 
spontaneously and consistently to the same organ. This 
tumour, the Lewis lung carcinoma (3LL), when implanted into 
the flanks on inbred C57B1 female mice, regularly 
metastasised to the lungs (Fig.l). The number and size of 
metastatic tumours in the lungs was directly related to 
the age of the primary tumour and the survival of the animal, 
This implied a continuous sloughing of tumour cells into the 
veins draining the primary tumour.
To simplify the identification of pulmonary métastasés, 
the alveoli were filled with dilute Indian ink before 
fixation of the whole lung. This had the effect of showing 
the métastasés as white nodules against the black substance 
of the lung, thus facilitating counting of the nodules 
(Fig.2). X-rays could also be used to identify pulmonary 
métastasés. The lungs were filled with Micropaque instead 
of ink (Fig.3).
Using the Lewis lung carcinoma as a model for drug 
screening, Hellmann and Burrage (1969) showed for the first 
time that it was possible by means of the cytostatic agent 
ICRF 159 to obtain complete suppression of the formation 
of spontaneous métastasés. The mode of action of ICRF 159 
has been investigated in some detail and forms the basis 
for the present thesis.
11
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Fig. 1.
C57B1 mouse bearing a 21 day 3LL tumour in the flank. The 
front of the rib cage has been removed and the heart displaced 
to show the presence of secondaries or métastasés in the 
lungs (arrowed).
12
Fig. 2.
C5 7B1 mouse lungs inflated with Indian ink and then fixed, 
demonstrating métastasés as white nodules.
Fig. 3.
X-rays of C57B1 mouse lungs filled with Micropaque. Métastasés 
are shown as black cut outs. Normal lungs are shown on right
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Inhibition of Metastatic Spread by ICRF 159
Salsbury ^  ^  (1970) demonstrated that treatment 
of the Lewis lung carcinoma with ICRF 159 inhibited 
pulmonary métastasés resulting from blood borne 
dissemination of 3LL cells. Tumours were inoculated 
into the flanks of inbred C57B1 female mice (Day 0). The 
animals were killed 3 weeks later (Day 21), and the lungs 
examined for métastasés. The lungs from animals treated 
with ICRF 159 showed no evidence of metastatic growth 
(Fig.4) in marked contrast to the control lungs which 
showed numerous metastatic nodules (Fig.5).
They suggested that the mode of action of ICRF. 159 
could have resulted from three different mechanisms:
1 The 3LL cells were killed by ICRF 159 during 
their carriage in the blood stream.
2 The 3LL cells failed to implant in the lungs or 
they implanted but did not grow.
3 The 3LL cells were not liberated from the primary 
tumour.
The last explanation was regarded as being the least likely 
of the alternatives.
Daily microscopical examination of blood concentrates 
and lung sections, however, showed the consistent presence 
from Day 10 onwards of circulating malignant cells in 
control animals and the complete absence of these cells 
(not even necrotic forms) in treated animals, thus ruling 
out the first two possibilities. The drug seemed, therefore 
to be acting in some way on the primary tumour.' Cross 
observations of excised 3LL tumours revealed a marked
14
Fig. 4.
No métastasés are seen in lungs from mice with 3LL tumours 
treated with ICRF 159.
Fig. 5.
Lungs of control mice showing numerous metastatic nodules.
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difference in colour, the control tumours being very red 
and haemorrhagic in contrast to the pale appearance of 
treated tumours.
The possible mechanism involved in the action of 
the drug was demonstrated by histological examination of 
the invading margins of the primary tumour. In control 
tumours the vasculature consisted largely of poorly defined 
sinusoids with red blood cells streaming between malignant 
cells. In many places malignant cells appeared to be in 
direct contact with blood cells, thus facilitating 
dissemination. On the other hand, treated tumours showed 
discrete well-formed blood vessels with malignant cells 
separated from the blood by a layer of endothelium.. These 
workers also pointed out that the growth rate of the primary 
implant was not significantly impeded by dosages of ICRF 159 
required to produce this antimetastatic effect. Therefore 
retardation of growth of the primary tumour could not alone 
account for the inhibition of metastasis formation by ICRF 
159. Comparable doses of cyclophosphamide had no effect on 
3LL tumour vasculature and the mice still developed 
pulmonary métastasés.
ICRF 159
Furst (1963) suggested that the majority of drugs which 
were known to inhibit tumour growth were, in fact, chelating 
agents. There were obviously many ways in which a chelating 
agent could interfere with cell growth providing the drug 
reached the appropriate site. EDTA, ethylene-diamine tetra 
acetic acid, one of the most powerful chelating agents had 
no significant anti tumour activity, Leiter e_t ^  (1959).
16
This result was not surprising since EDTA, being a highly 
polar molecule would not be expected to pass through 
biological membranes such as the cell wall. Creighton 
et al (1969) suggested that relatively non-polar derivatives 
of EDTA would be more likely to reach vulnerable sites, and 
once there, might break down to give potent chelating agents. 
Any selective antitumour action would depend on there being 
differences between normal and tumour cells; for instance, 
very small variations in trace metal, calcium or magnesium 
ion concentrations at specific sites might be sufficient to 
allow a differential effect.
Initial screening results with the first compound made, 
1,2,bis(3,5-dioxopiperazin-l-yl) ethane (ICRF 154), were 
encouraging and further derivatives of EDTA were therefore 
made.
Antitumour activity was confined to a group of compounds 
very closely related to ICRF 154. Any lengthening of the 
central bridge or ring substitution resulted in complete loss 
of activity. It was retained however by methyl, though not 
ethyl substitution of the central bridge, viz. (^)-1,2,-bis 
(3,5 dioxopiperazin-l-yl) propane (ICRF 159).
The formulae of the two compounds are shown in Fig.6.
ICRF 159 is a potent antimitotic agent, rather than a 
general cytotoxic agent, in that it stops cell division only 
during a very brief period of the generation cycle as shown 
by Hellmann and Field (1970) using a quantitative cell 
culture technique with human epithelial (H Ep/2) cells. 
Further investigation by Sharpe e_t ^  (19 70) revealed that 
mitotic figures in human lymphocytes grown in culture were
17
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drastically reduced by the drug and the cells arrested in 
early and late prophase. It was concluded that the drug 
acts on the cells at the end of G2 phase or the early 
mitotic phases of the cell generation cycle.
The Present Study
In the present study an attempt has been made to 
demonstrate the nature of the changes occurring in the 
structure and function of 3LL blood vessels brought about 
by treatment with ICRF 159. The vascular morphology of the 
rat Walker tumour has also been studied following treatment 
with ICRF 159. This non-metastasising tumour was chosen, 
as Tucker (1970) had previously demonstrated that ICRF 159 
produced a blanching of this neoplasm when it was grown on 
the chorio-allantoic membrane (CAM) of chick embryos. Changes 
in the vasculature of the tumour were demonstrated by X-ray 
angiography, carbon black (Pelikan ink) labelling, and 
intravital staining with lissamine green.
Any alteration of the morphology of tumour blood vessels 
may affect the rate of blood flow through the tumour. As 
this could be a critical factor in therapeutic considerations, 
the blood flow rates of 3LL tumours treated with ICRF 159 
were measured.
Also the effect of serotonin on control and ICRF 159 
treated 3LL tumours was tested, as it has been demonstrated 
that blood vessels in some tumours were abnormally sensitive 
to serotonin at doses which had little effect upon circulation 
in muscle tissue.
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Finally, the vitality of 3LL cells in areas of control 
and ICRF 159 treated tumours devoid of functional blood 
vessels was demonstrated and discussed in relation to the 
poor results of chemotherapy and/or radiotherapy against 
large tumours.
This thesis is presented in the following Sections
Section II
Section III
Section IV
Section V
Section VI
The morphology of the blood vessels of 3LL 
and Walker tumours after treatment with ICRF 
159.
The measurement of blood flow in 3LL tumours 
after treatment with ICRF 159.
The effect of serotonin on 3LL tumours after 
treatment with ICRF 159.
The vitality of 3LL cells in areas of control 
and ICRF 159 treated tumours devoid of 
functional blood vessels.
Ceneral discussion and conclusions.
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SECTION II
The morphology of the blood vessels of 3LL and 
Walker tumours after treatment with ICRF 159
21
INTRODUCTION 
Morphological studies
The vascular architecture of spontaneous and trans­
planted tumours has been studied intensively since the 
beginning of this century. Of the many historical accounts, 
those of Coldacre and Sylven (1962) and Urbach (1963) have 
been used extensively in this review of the literature.
Borst (1902), Ribbert (1904) and Apolant (1906) 
reported that most spontaneous malignant tumours were poorly 
and irregularly supplied with blood vessels especially in
central regions. There were marked changes in existing
vessels such as defective vessel walls, thrombosis, 
obliteration and dilation. However, the density of the 
vascular bed at the periphery of the tumour was generally 
increased.
One of the earliest descriptions of the anatomy of 
tumour blood vessels was presented in a series of papers by 
Coldmann (1911) using intra-arterial injections of Indian 
ink into living animals. His findings with transplanted 
mouse tumours may be summarised as follows :
1, There was marked proliferation of blood vessels at 
the periphery of the tumour. The vessels were 
usually dilated and spiral in appearance.
2. The architecture of tumour vessels was very
irregular with numerous random anastomoses forming 
vascular networks. There were direct transitions 
from arteries to capillaries and then 'to veins with 
few vessels analogous to arterioles and venules.
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3. As the tumours grew, the number of central 
blood vessels diminished and tumour cells 
invaded the pre-existing venules of host 
organs.
Lewis (1927) studied the vascular patterns of trans­
planted rat tumours by intra-aortic injections of Indian 
ink into dead animals. He noted the considerable variations 
in tumour vascular patterns which could be encountered. 
Adenocarcinomas presented a highly irregular arrangement 
with large dilated sinusoidal vessels showing no 
differentiation into arterioles and venules, as opposed to 
adenofibromas of the breast which demonstrated a normal 
vascular pattern with large afferent and efferent vessels 
gradually breaking up into capillary plexuses. He suggested 
that the vessels were formed under the influence of the 
neoplasm and that the development of central necrosis was 
not necessarily a result of poor blood supply, but of other 
factors such as the continued multiplication of the tumour 
cells exerting undue pressure on the capillaries or 
preventing in some way the further penetration of the 
capillaries into the central areas.
Waters and.Green (1959) studied the morphology of the 
vascular system of two transplantable granulosa-cell tumours 
of mice by means of histological sections and Indian ink- 
injected, cleared, whole mounts. The, tumour vessels were 
always primitive sinusoids with relatively small amounts of 
connective tissue around them.
The development of the transparent ear chamber technique, 
Clarke et al (1931), made it possible to study the development 
of tumour vascularity in vivo. Thus Ide et al (1939) studied
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the growth of explanted Brown-Pearce rabbit epitheliomas, 
and observed marked proliferation of vessels especially 
at the periphery of the tumour within 3-8 days following 
implantation. Tumour growth was grossly visible within 
24 hours following the beginning of blood vessel growth.
Blood vessel growth was orderly and characteristic, following 
a definite corona-like arrangement not observed in the normal 
tissues used as controls. All the normal mechanisms of blood 
vessel growth were found, such as buds, loops and anastomoses, 
but the speed of development was greatly increased over that 
of the controls. Control tissue transplants (liver, skin and 
kidney) were observed under the same conditions. Vascular 
development was observed 6 days after implantation of a piece 
of liver. This initial response did not develop and by the 
14th day the liver fragment had been completely absorbed, so 
that all that remained was the pattern of the original stroma. 
Implants of skin and kidney also failed to elicit a sustained 
vascular development.
Though Coldmann, and Lewis, and Ide, Baker and Warren, 
had shown to the contrary, it was still thought that tumours 
had a poor blood supply. It was not until the significant 
works of Algire and Chalkley (1945) that tumours were thought 
to have a 'superior' blood supply in comparison to normal 
tissue. They used the transparent chamber technique to study 
tumour growth vivo and compared it with the surrounding 
connective tissue, healing wounds, normal subcutaneous tissue, 
and liver tissue grafts. They observed that in transplanted 
sarcomas and mammary gland carcinomas, vascular proliferation 
occurred as early as 3 days after implantation compared with 
6 days for wounds and subcutaneous tissue. Most of the 
newly-formed vessels consisted of endothelial channels of 
wide diameter with little or no differentiation into
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arterioles or venules. The vascular density of the tumour 
implant increased rapidly to almost double that of the 
surrounding tissue and then remained fairly constant at 
this higher level. From such observations, the concept of 
"preferred nutritional status" of solid tumours arose.
They also suggested that the primary difference between 
normal and malignant cells was that the latter had an 
inherent capability of eliciting continued new capillary 
endothelium from the host. However, this premise was soon 
contradicted by Williams (1951) studying the V2 carcinoma 
of Kidd and Rous grown in the rabbit ear chamber, where it 
was found that this tumour had no ability to stimulate the 
growth of vessels.
Many authors have reported progressive vaso-proliferation 
of neoplasms but the source and nature of the stimulus to 
the host's vessels are unknown. This gave rise to the 
hypothesis that humoral substances induce vasoproliferation 
(Chalkley, 1948; Williams, 1959; Urbach and Craham, 1962 and 
Warren and Shubik, 1966).
The first evidence for the humoral induction of tumour 
blood vessels was demonstrated by Creenblatt and Shubik 
(1968). Vasoproliferative activity was consistently seen 
in hamster cheek pouch stroma adjacent to tumour implants, 
despite separation of the stroma and tumour by a millipore 
filter which prevented the passage of cells. Similar 
results were reported by Erhmann and Knoth (1968) using 
choriocarcinoma and Warren e^ ^  (1972) with Fortner 
melanoma, both in the hamster cheek pouch. Folkman (1971) 
has recently isolated from human and animal timiour cells a 
humoral factor which is mitogenic for capillary endothelium.
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This tumour-angiogenesis factor (TAF), when injected 
continuously into the dorsal air-sac of a rat, induced new 
capillary proliferation within 48 hours. TAF, consisting 
of protein (10%), ribonucleic acid (25%), carbohydrate (50%), 
and the rest lipoidal material, has not been isolated, in 
normal tissue with the exception of human placenta.
These results gave rise to the possibility of inhibiting 
tumour growth by antagonising the action of TAF, a concept 
known as anti-angiogenesis.
Evidence was accumulated to show that neovascularization 
was a necessary condition for the growth of a solid tumour 
in two experimental conditions.
In the first case Greene (1941) transplanted heterologous 
tumours in guinea pig eyes and observed that some implants 
which did not vascularize, failed to grow for more than 1 
year. However, when these dormant tumours were re-implanted 
into their original host, progressive vasoproliferatiori and 
tumour growth occurred. Similarly, when Gimbrone £t al (1972) 
implanted small fragments of Brown-Pearce carcinoma directly 
on the iris in rabbits, the tumours vascularized and grew 
characteristically, destroying the eye within 2 weeks. In 
contrast, when implants were placed in the anterior chamber, 
they remained dormant for up to 6 weeks. 'When re-implanted 
on the iris, vascularization was followed by rapid invasive 
growth.
The second experimental situation involved isolated 
preparations of dog thyroid or intestinal segments which 
were perfused on average for 11 days with a mixture of human 
haemoglobin, calf serum and Eagle's medium. Folkman e_t aT 
(1962 and 1963) demonstrated that these isolated perfused
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preparations would accept a tumour from another species. 
Implants of mouse melanoma grew only to a small size 
(2-3mm diameter) but no further, as a result of failure 
of neovascularization. Histological studies invariably 
demonstrated degeneration of capillary endothelium in 
these perfused tissues - Gimbrona _et ^  (1969) and Folkman 
et al (1966).
As a result of such observations, Folkman and his group 
are currently investigating methods of inhibiting the 
production of TAF and preventing tumour vascularization and 
therefore tumour growth.
A number of investigators have studied the vasculature 
of tumours by utilising either angiography or post-mortem 
injection of organs with radio-opaque dyes and subsequent 
radiography. Sampson (1912) injected radio-opaque lead and 
bismuth in his investigation of the blood supply of uterine 
myomata.
Kanno (1934) studied the effects of transplanting 
rabbit sarcoma on the blood vessels of various "host" organs 
in the rabbit, whilst Hasegawa (1934) concentrated on the 
blood supply of subcutaneous implants of sarcomat _ous 
tissue also in the rabbit.
One of the most extensive angiographic studies was 
carried out by Shinkawa (1939) in which he reported a marked 
increase in arterial blood supply.during the early stages 
of growth of transplanted fowl sarcomas. This paper also 
contains an extensive review of angiographic references 
from 1910 to 1932. In accordance with Braithwaite (1958) 
and Margulis et al (1961) these authors reported that
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haemorrhagic zones, as manifested by leaks of radio-opaque 
material, were a constant and prominent feature especially 
near the centre of the tumour.
Angiography has been found to be extremely useful in 
the study of bone tumours in humans. (Farinas, 1937;
Inclan, 1942; Dos Santos, 1950; Lasser and Schowingen, 1955; 
Schobinger e_t al, 1958.)
Billing and Lindgren (1944) and Lindgren (1945) combined 
radiography with histology to study the vascular supply of 
several human tumours. Tumour vessels were generally 
primitive, their walls lacking elastic lamellae. These 
workers also suggested that the capillary angioarchitecture 
of tumours was characteristic to a certain extent. This was 
especially true for highly differentiated tumours - e.g. 
hemangiomas. Margulis ^  al (1961) found similarly that 
various mouse tumours had characteristic angiographic 
appearances. For example, angiograms of sarcoma 37 showed 
many randomly arranged, dilated blood vessels interspersed 
with ill-defined ’lakes' filled with contrast medium. On 
the other hand, angiograms of squamous cell carcinomas 
showed only a few large vessels with ho 'lakes'.
Rubin 2Ë ^  (1964) pointed out the discrepancies of 
microangiography as a technique, in that the vascular 
architecture of tumours was not demonstrated under 
physiological conditions. They also stressed the importance 
of standardising the variables of any angiographic technique, 
i.e. making sure that the contrast medium was injected at 
the same pressure and for the same duration if a comparison 
of tumour vascular patterns was to be made.
28
However, microangiography has been employed in the 
study of the microcirculation of tumours, Lagergren ^  ^  
(1958); McAlister and Margulis (1963). Rubin and Casarett 
(1966) gave a detailed study of the Walker carcinosarcoma 
and the Murphy-Sturm lymphosarcoma tumours in rats. The 
vasculature in the Walker tumour was irregular and 
disorderly and confined to a thin outer cortex surrounding 
a central zone of necrosis. In contrast, lymphosarcomas 
showed little necrosis and a regular and orderly 
vasculature. They also suggested that there was an 
improvement of the tumour microcirculation following a 
course of radiation. Similar results were reported by 
Reinhold (1971) with the microcirculation of a mouse 
mammary tumour.
In summary, the blood vessels of transplanted tumours 
consist of the pre-existing vessels of the host and newly- 
formed vessels derived from them. In the host tissues, 
veins.often suffer invasion and occlusion whilst the 
arteries long remain intact* As reviewed, the newly-formed 
tumour vessels have been described as tortuous, irregular 
and sinusoidal with a disorderly or chaotic branching 
arrangement. Newly-formed vessels in malignant tumours 
are usually small and often simple in structure, especially 
in the more rapidly growing tumours where the vessels 
consist of little more than irregular channels lined either 
by endothelium or by tumour cells alone. Many tumours, 
whilst growing in their peripheral regions, develop a 
central zone of necrosis, due to an inadequate growth of 
new blood vessels or a suicidal occlusion of the vessels 
already present.
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MATERIALS AND METHODS 
Lewis lung carcinoma (3LL)
This tumour originated spontaneously as a carcinoma 
of the lung of a C5 7B1 mouse in 1951. The tumour, as 
described by Sigiura and Stock (1955), is a very malignant 
type of epidermoid carcinoma (anaplastic carcinoma) which 
becomes extremely haemorrhagic. Subcutaneous injections 
of fresh blood of mice bearing the Lewis lung carcinoma 
into new hosts produce identical tumours. This tumour 
has been transplanted routinely in the Department of Cancer 
Chemotherapy since 1966.
Tumours were inoculated subcutaneously by means of a 
Bashford needle into the flanks of inbred C57B1 female 
mice weighing between 18 and 22g. Each implant was 
approximately 0.1ml in volume and weighed about O.lgm. 
Aseptic precautions were observed.
Experimental mice received ICRF 159 30mg/kg suspended 
in 0.2ml of carboxymethyl cellulose (0.5%) in isotonic 
saline (CMC) given intraperitoneally. Control mice 
received 0.2ml of CMC alone intraperitoneally.
The first dose of the compound was administered 24 
hours after implantation and the schedule of injections 
was that used routinely in the Department of Cancer 
Chemotherapy (Table 1).
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TABLE 1
Days after implantation on Days after implantation on
which injections were given which primary tumours
(inclusive) removed
1 - 4  7
1 - 4 ,  7 - 9  10
1 - 4 ,  7 - 1 1  14
1 - 4 ,  7 - 11, 14 21
Walker carcinosarcoma
This rapidly growing tumour developed spontaneously 
in the region of the mammary gland of a pregnant albino 
rat in 1928 in the laboratory of George Walker at the 
John Hopkins University School of Medicine. This tumour, 
as described by Stewart e_t ^  (1959) , is an adenocarcinoma 
and is characterised by a large central necrotic zone 
surrounded by a thin viable zone usually only a few 
millimetres thick. The tumour has been maintained in this 
Department in an ascites form.
The tumour was maintained by weekly ascites trans­
plantation to male Sprague-Dawley rats weighing between 
150 and 200gms. When solid Walker tumours were required
0.3ml of ascites huffy coat (ascites fluid was centrifuged 
at 2,500 r.p.m. for 5 minutes) were injected subcutaneously 
into the flank. Tumours studied ranged from 4 to 10 days 
old.
Experimental rats received ICRF 159 50mg/kg suspended 
in 0.4ml of CMC solution given intraperitoneally daily. 
Controls received 0.4ml of CMC alone.
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In all experiments food and water were given ad 
libitum throughout.
1 Radiographic procedure
Ninety-two C5 7B1 mice with 3LL tumours were used for 
angiographic studies of which sixty-seven angiograms were 
of sufficiently high standard to be used for evaluation.
Thirty Sprague-Dawley rats with Walker tumours were 
also used, of which sixteen angiograms were of a 
sufficiently high standard.
Various methods for the injection of contrast media 
in bromethol (Avertin) anaesthetised animals were tried, 
but retrograde intravenous injection proved most effective 
in demonstrating tumour blood supply. Micropaque (aqueous 
barium sulphate about loz/fl oz (55g/50ml)) was injected 
through a polythene catheter introduced into the inferior 
vena cava through the exposed right heart (Margulis et al, 
1961). Care was taken to give the contrast medium in the 
same volume and identical manner each time.
Animals were placed in a supine position on a trans­
parent tray with the X-ray tube 18in (46cm) above. X-ray 
film was placed on a shelf 18in (46cm) below and each 
radiograph was therefore twice life-size. Focal spot of 
the X-ray tube was 0.3mm and the exposure was usually:
Mice - 12 mAS 50 mA 42KV
Rats - 32 mAS 40 mA 48KV
Each film was developed for 6 minutes, overdeveloping
by 1 minute to obtain contrast (Parish e± 1964).
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11 In vivo blood vessel labelling
Sixty-four C5 7B1 mice with 3LL tumours and eighteen 
Sprague-Dawley rats with Walker tumours were used in these 
experiments.
I
The Pelikan ink technique (Majno ejt aT, 1961) was 
used to study the physiological state of tumour blood 
vessels vivo.
A colloidal suspension of carbon black (Pelikan 
biological ink Cll/143a) diluted 1:4 with 1% gelatine in 
sterile saline was used (Oswald and Cater, 1969). This 
suspension contains about lOmg/ml of carbon with an average 
particle size of 20oS; it is stabilised with 4.5% fish 
glue and contains 1.3% phenol as a preservative.
Mice (C57B1) inoculated with 3LL tumour and treated 
with ICRF 159 or CMC received 0.12ml of the diluted ink pe>r 
20gm mouse into the lateral tail vein. 0.75ml(per 150gm 
Sprague-Dawley rat)of the diluted ink was similarly injected 
i.v. into rats inoculated with the Walker carcinosarcoma 
treated with ICRF 159 or CMC.
The animals were left for 1 hour by which time the ink 
was cleared from the circulation. The animals were then 
killed, the tumour and surrounding tissue were quickly 
removed, placed in 10% formol saline for 14 days and then 
washed in distilled water for 24 hours before being trans­
ferred to 12. gelatine at 37°C for 24 hours and then for 
another 24 hours into 25% gelatine also at 37°C. The 
blocks were embedded in 25% gelatine and stored in formol 
saline. Frozen sections, cut at 25-35p were lightly
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stained with alum carmine and mounted in Highman's 
mountant. At least eight frozen sections cut randomly 
from each tumour were examined.
Random areas of the 3LL primary tumours were examined 
with the electron microscope in order to locate the 
position of the ink within the blood vessels.
The tissues were fixed in 4% glutaraldehyde in 
phosphate buffer for 1 hour and then post-fixed for a 
further hour in phosphate buffered osmic acid, and 
embedded in Araldite.
Sections (about 40oS) were cut on a Porter-Blum 
microtome equipped with a glass knife and stained with 25% 
uranyl acetate in methanol for 10 minutes - washed in 
methanol and then further stained in lead citrate for 4 
minutes and washed in distilled water. Sections were 
lightly coated with carbon and examined in Siemens 
Elmiskip 1 electron microscope.
Some 3LL tumours were excised 5 minutes after 
intravenous injections of ink, and thick cryostat sections , 
stained with neutral red, were examined.
Ill Intravital staining with Lissamine Green
The technique described by Goldacre and Sylven (1959 
and 1962) using the triphenyl methane dye, lissamine 
green, was employed for studying tumour blood supply.
The dye is non-toxic and non-reactive and can be 
tolerated by tumour bearing animals even when injected in 
large amounts.
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The dye, which readily enters the interstitial fluid, 
colours the animal and the vascularized part of the tumour 
within seconds of i.v injection or within 30 minutes of
i.p. injection.
Thirty-six mice inoculated with 3LL tumours and treated 
with ICRF 159 or CMC received 0.5-lml of a 2% lissamine 
green solution, rapidly injected into the tail vein.
Up to 5 millilitres of 2% lissamine green solution 
was similarly injected into twenty rats inoculated with the 
Walker carcinosarcoma and treated with ICRF 159 or CMC.
The animals were exsanguinated under ether 5 minutes after 
the injection of lissamine green. The tumours were bisected 
and examined.
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RESULTS
X-ray angiography
Injection of Micropaque by the tail vein proved 
difficult and thé radiographs were difficult to interpret 
because the contrast medium had circulated around the 
heart and thus into the arterial system (Fig.7).
Arteriograms taken after injecting Micropaque down 
the aorta demonstrated the larger arteries of the body 
but not those of the tumour (Fig.8).
Retrograde intravenous injections of Micropaque proved 
most effective in demonstrating the blood supply of control 
and ICRF 159 treated tumours.
The following observations were made on 3LL venograms:
Host vessels : No new vessels were seen to develop in
response to the tumour, but host vessels draining the tumour 
were constantly dilated and some of these vessels became 
very tortuous (Fig.9). Identical appearances were seen in 
animals where the.tumour was treated with ICRF 159. At the 
border of the tumour, angiographic appearances became very 
indistinct owing to vascular proliferation (Fig.10). It 
was not possible to distinguish whether this proliferation 
was in the host or the tumour tissues. Again the angio­
graphic picture was the same for both control and treated 
tumours.
Tumour vessels: Control tumours showed large filling
defects whose size and position varied from tumour to 
tumour. Such vascularization as there was appeared to be
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Fig. 7
Vascular system of a C5 7B1 mouse bearing a 10 day 3LL tumour. 
Micropaque injected into the tail vein circulated round the 
heart and into the arterial system.
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Fig. 8.
Arteriogram of a C5 7B1 mouse bearing a 14 day 3LL tumour, 
Little detail of the tumour vasculature can be seen.
38
Fig. 9.
Venogram of a primary 3LL tumour 14 days after implantation 
and treated with ICRF 159. Note the dilated vessels draining 
the tumour and the tortuous appearance of one of these vessels
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Fig. 10.
Vascular proliferation at the periphery of a 21 day 3LL 
control tumour.
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randomly arranged with vessels often ending abruptly 
(Fig.11). This proved to be the constant picture in the 
control tumours. When the tumour was cut at apparently 
avascular areas, Micropaque flowed out from the cut 
surfaces. Tumours of the treated mice, however, showed 
numerous discrete blood vessels with some indication of 
a regular vascular arrangement (Fig.12).
Walker tumour host vessels: Large new vessels did
not develop in response to the tumour. On the other hand, 
three main host vessels - the lateral thoracid-cutaneous, 
the ilio-lumbar, and the inferior epigastric veins - were 
always considerably dilated, presumably to meet the 
demands of outflow from the tumour (Fig.13). Essentially 
the same picture was seen in ICRF 159 treated and control 
tumours. At the margins of the tumour, however, there 
was considerable proliferation of blood vessels in both 
treated and control tumours (Fig.14).
Tumour vessels: In the tumours themselves, there
was a marked contrast between treated and controls. The 
control tumours showed signs of pooling of the Micropaque; 
there were avascular areas of varying size and position. 
The dilated vessels were randomly arranged and irregular, 
all of which is characteristic of tumour blood vessels 
(Fig.15). The treated tumours, however, showed no signs 
of pooling and the blood vessels presented a more orderly 
arrangement. There was little evidence of any cork­
screwing (Fig.16).
Pelikan ink labelling
3LL
In thick frozen sections of primary treated tumours
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Fig. 11.
Venograms of control 
3LL tumours.
14 day tumour
Note in both cases 
there are areas of 
the tumours which 
are apparently 
avascular. Also 
note that many of 
the tumour vessels 
end abruptly.
21 day tumour
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Fig. 12.
Venograms of ICRF 159 
treated 3LL tumours.
14 day tumour
Note that the tumours 
are well vascularized 
with some indication 
in the 14 day tumour 
of a regular vessel 
arrangement.
21 day tumour
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Fig. 13
Venogram of a Spragne-Dawley rat bearing a 7 day control 
Walker tumour. Note again the three main vessels draining 
the tumour.
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Fig. 14.
Marked proliferation of vessels at the periphery of an 
excised 8 day control Walker tumour.
m45
Fig. 15.
Venogram of a control 
Walker tumour 7 days 
after implantation. 
Note the large 
avascular areas and 
the pooling of 
Micropaque. Many 
of the vessels are 
cork-screw in 
appearance whilst 
others end abruptly.
Fig. 16.
Venogram of an ICRF 
159 treated Walker 
tumour 7 days after 
implantation. There 
are no avascular 
areas and no signs 
of pooling.
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the ink was largely cleared thus showing little labelling 
(Fig.17) but in control tumours, vessels were clearly 
outlined with ink (Fig.18). With older and therefore more 
necrotic tumours (21 days) the differences between the 
groups became much less apparent (Figs.19 & 20).
Electron micrographs of control tumour vessels 
showed deposits of carbon trapped between basement membrane 
and an abnormal endothelium (Fig.21).
Walker tumour
With this tumour, treatment with ICRF 159 also reduced, 
but by no means abolished, the number of labelled vessels. 
Marked vascular labelling was always found in both control 
and treated tumours near areas of haemorrhage and necrosis. 
However, with this rapidly growing tumour, the results are 
more difficult to interpret because anatomical flaws in the 
labelled vessels are a real possibility due to their rapid 
formation. Fig.22 demonstrates the ink trapped round the 
periphery of the tumour blood vessels.
Intra-vital staining
3LL
Gross observations revealed no differences between 
control and treated tumours at similar ages after tumour 
implantation. As the tumour increased in size the peripheral 
vascularized zone became markedly reduced. There were no 
avascular, colourless, areas in the tumour periphery.
The youngest tumours (7days, approx.0.8cm across) were 
usually coloured throughout, whereas in the oldest
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Fig. 17
Frozen section of a primary 3LL tumour 14 days after 
implantation and treated with ICRF 159. The tumour was 
excised 1 hour after i.v. injection of Pelikan ink.
(Alum carmine x 50.) Note the absence of vascular labelling.
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Fig. 18.
Frozen section of a primary 3LL control tumour 14 days after 
implantation. The tumour was excised 1 hour after i.v. 
injection of Pelikan ink. (Alum carmine x 50.) Many vessels 
are clearly outlined with ink.
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21 day treated 3LL tumour - some vessels are clearly outlined 
(Alum carmine x 50.)
Fig. 20
Section from 21 day control 3LL tumour showing some labelled 
vessels and some extravascular carbon. (Alum carmine x 50.)
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Fig. 21.
Carbon particles trapped between the basement membrane and 
an endothelial cell of a 14 day control 3LL tumour blood
vessel.
endothelial cell
lumen of the blood vessel
Plate magnification = IK 
Print magnification = 3%K
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Fig. 22
This section is taken from a 10 day old control Walker 
tumour and demonstrates the carbon particles trapped 
around the periphery of a number of blood vessels cut 
in cross section. (Alum carmine x 100.)
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tumours (21 days, approx.2.0cm across) the peripheral 
vascularized zone was only a few millimetres thick. 
There was a complete absence of dye from the central 
necrotic region (Fig.23).
Walker tumour
Again gross observations revealed no differences 
between control and treated tumours. In Walker tumours 
ranging from 4 to 10 days old there was an increase in 
the size of the necrotic centre until in the largest 
tumours, only a very thin peripheral vascularized zone 
remained (Fig.24).
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Day Lewis Lung; 
Control.
Fig. 23.
21 day control 3LL tumour showing a complete absence of dye 
from the central zone.
10 bay ..alker 
Control.
Fig. 24.
10 day control Walker tumour. ’ Note the dye is confined only 
to a thin peripheral zone of the tumour.
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DISCUSSION
Willis (1952) in his classic work on "The Spread of 
Tumours in the Human Body", points out that: "The
structure of new-formed blood vessels in malignant tumours 
rarely approaches that of normal veins or arteries and the 
more rapidly growing the tumour, the more imperfect is the
architecture of the vessels ......  in highly anaplastic
growths, carcinomas as well as sarcomas, even the endo­
thelium may be incomplete in places and the vascular 
channels lined in part by tumour cells". Clearly such 
imperfections of vascular structure must favour 
dissemination of malignant cells. Willis's statement 
applies with equal force to the Lewis lung carcinoma of 
the mouse (Salsbury e_t 1970).
Previous observations indicated however, that the 
structurally imperfect vascular architecture of the 3LL 
tumour can be improved by treatment with ICRF 159 (Salsbury 
et al, 1970) ,and the present results lend support to the 
assumption that treatment with this drug normalizes 3LL 
vasculature functionally as well as morphologically.
They also strengthen the conclusion that treatment with 
ICRF 159 prevents pulmonary métastasés,because malignant 
cells unable to penetrate the normalized blood vessels 
cannot reach the blood stream and are thus unable to escape 
from the primary tumour.
Although it seems clear that as in other tumours the 
3LL and the Walker have an outer shell of rapidly 
proliferating tumour cells,permeated by a leash of im­
perfectly formed and randomly arranged vascular sinusoids, 
certain aspects of the angiograms call for comment. Le 
Serve (1971) and Le Serve and Hellmann (1972).
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In 3LL control tumours, Micropaque diffuses into the 
wide spaces of the sinusoids in a "river-delta" effect, 
but because of the limitations of the resolution of the 
X-ray technique, radiopaque material cannot be demonstrated. 
The filling defects are therefore more apparent than real 
because if the tumours are sectioned at these "avascular" 
areas Micropaque flows out from the cut surfaces. In 
treated tumours, however, the Micropaque is confined to the 
discrete vascular channels and consequently can be seen on 
the angiograms. This difference in the tumour vascular 
pattern is more clearly seen with the larger Walker tumour.
In Pelikan ink studies also, where tumours were excised 
5 minutes after i.v. injection, the ink distributed itself 
throughout extra and intravascular spaces in the controls, 
but remained confined to the vessels in the treated tumours. 
The lissamine green injections provide further confirmation 
that the filling defects in the control venograms reflect 
only inadequacies in the degree of fine resolution of the 
angiograms.
The lissamine green injections also reveal that in both 
treated and control tumours, vascularization is confined to 
an outer zone or cortex which encapsulates the tumours, but 
that the larger central and probably necrotic medulla appears 
not to be reached by the dye. It can be assumed therefore, 
that Micropaque is also confined to the peripheral zone and 
that the vessels seen on the angiograms are in the cortex.
Thus a three dimensional picture of the tumour blood supply 
can be built up. The central, unstained part of these 
tumours is referred to as necrotic in this thesis, although, 
as demonstrated in Section V, this zone contains viable cells, 
despite an absence of functional blood vessels.
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The abnormal character of tumour blood vessels and 
their functional normalization by ICRF 159 is indicated 
by the Pelikan ink experiments.
The Pelikan ink technique of Majno e^ aT (1961) is 
used to outline inflamed vessels. The principle is that 
the ink injected i.v. will pass through gaps in the 
vascular endothelium caused by inflammatory agents, but 
will be retained by the intact basement membrane, thus 
outlining the vessels.
In this investigation as no inflammatory agents are 
administered, this technique gives an indication as to the 
"state" of the tumour blood vessels iu vivo. Basically, 
there are four alternatives as to the fate of the ink;
1. In well-formed blood vessels unaffected by 
inflammatory agents etc., the ink will pass through 
and be cleared into the liver, spleen and kidney.
2. In vessels with a malformed endothelium, but an intact 
basement membrane, the ink will leak through any gaps 
and become trapped, thus labelling the vessel.
3. If the vessel has completely broken down with 
resulting haemorrhage, the ink will diffuse with the 
blood cells into the surrounding tissue,
4. Tumours and tumour vessels are in a constant state of 
pathological change. In the one hour allowed for the 
ink to clear from the blood system, some vessels will 
have been occluded and it is possible that ink could 
be trapped in that situation.
Goldacre and Sylven (1962) using injections of L.G., 
observed patent vessels containing intact red cells in
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white tumour regions while the blood in the rest of the 
body was dark green - i.e. occluded but patent tumour 
vessels.
The E.M. study on the 3LL primary supported the second 
alternative for the ink's fate, showing the ink trapped 
between the intact basement membrane and the endothelial 
cells.
The venules have been found to be the main site of 
vascular leakage, even when the inflammatory agent is 
administered from the arterial side (Gabbiani e_t 1970).
In these tumour vessels the labelling is non-specific. It 
is possible that the labelled vessels have anatomical flaws 
due to their rapid formation, but at the dose of ICRF 159 
used in this experiment, there is little inhibition of 
tumour growth, so this would not explain the difference in 
the amounts of carbon found in control and treated tumours.
It may be that the tumour vessels are inflamed by local 
effects of anoxia and necrosis. This would not account for 
the labelling to appear as early as Day 10 in the controls, 
that is, before the tumour has become very necrotic.. ICRF 
159 does not markedly decrease the degree of necrosis in 
the 3LL primary tumour anyway and so why is the labelling 
confined to the control tumour vessels? It is very important 
to distinguish between labelling in areas of actively 
dividing tumour cells and in necrotic areas. Labelling was 
noticed in the latter case, but was not thought to be of 
much significance because one would expect blood vessels to 
be in various stages of degradation when in close proximity 
to necrotic areas. It was the peripheral labelling that 
was thought to be functionally important.
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The ink has been administered without inflammatory 
agents to give a guide as to the state of these tumour 
blood vessels vivo. By means of histological evidence, 
we can see the differences caused by ICRF 159 on the blood 
vessels of the 3LL primary - that is, "the well-formed" 
endothelium (Salsbury e_t aT, 1970), but there is no 
indication as to whether these vessels are well-formed in 
physiological terms.
This Pelikan ink test gives valuable information in 
that it tells us whether Jut. vivo, the 159-treated tumour 
vessels are well-formed, or whether there are endothelial 
gaps, or whether endothelial breakdown is occurring. From 
this view, the lack of ink in the 159-treated tumours 
would suggest that the blood vessels are well-formed and 
that the ink has passed through the tumour, whereas in the 
controls there are real signs of disintegration of blood 
vessel structure. Similar results were reported by Dayal 
(1970) with the Gardner lymphosarcoma in which the absence 
of carbon labelling was linked with the normal appearance 
of the tumour blood vessels.
Specific alterations of tumour blood vessels could 
have considerable consequences for the treatment of tumours. 
This angiometamorphic effect may mean that in treated 
tumours the rate of blood flow is significantly higher than 
in control tumours and that consequently the availability 
of anticancer drugs might be increased. This consideration 
is examined in Section III of this thesis.
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An attempt to grow two dimensional 3LL tumours
Many of the major works on the vascular architecture 
of tumours have involved the use of transparent chamber 
techniques, in which tumours grow as a sheet only a few 
millimetres thick. This makes it possible to observe 
microscopically the daily development of the tumour vascular 
system in the same animal. Also it permits the direct study 
of the tumour vessels under various physiological conditions.
With this in mind, experiments were set up in which 
attempts were made to grow thin 3LL tumours not in mice but. 
on the highly vascular chorio-allantoic membrane (CAM) of 
chick embryos, as described by Tucker (1970). This would 
enable the vascular patterns of 3LL tumours to be established 
and to observe the daily effect of ICRF 159 on the 
development of the tumour vessels.
As the chick embryo is immunologically immature during 
the first two weeks of its development, heterologous tumours 
can be grown on the CAM without the problems of immunological 
rejection.
For the experiments, fertilised brown Leghorn eggs were 
incubated at 37.5°C and candled on the eighth day to 
determine the position of a suitable vascular area of the 
CAM for tumour growth. Above this area of the CAM, a 
rectangle approximately 2.0cm x 1.5cm, was marked with a 
pencil and cut into the shell with a dental drill, taking 
great care not to damage the attached membrane. A small 
hole was ground in the centre of the rectangle through which 
a small drop of saline was gently manoeuvered. , The
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weight of the saline usually caused the membrane to drop 
away from the inside of the shell. If this did not occur, 
however, suction with a rubber teat, applied to a hole made 
in the air-sac end of the shell, aided the dropping of the 
CAM. The area of shell within the rectangle was then 
removed with sterile forceps leaving a window through which 
the required vascular area of the CAM was accessible. The 
windows in the shell were then sealed with Sellotape and 
the eggs put back in the incubator until required.
Various attempts were made using different techniques 
to grow two dimensional 3LL tumours.
q
A small volume (approximately 1mm ) of 3LL mash from 
10 day old tumours was placed either directly on, or in 
close proximity to, various vessels of the CAM. Over the 
implant was placed a plexiglass diffusion chamber ring 
(14mm diameter and 2mm thick) with a coverslip cemented to 
the upper surface. This permitted direct observation of 
the tumour whilst limiting its upward growth (Fig.25).
In a number of eggs, 3LL tumours were grown on grids 
made from polytetrafluoroethylene mesh. This technique 
was the most successful used by Tucker in terms of 
reproducible tumour growth.
Finally, in other eggs, the tumour mash was simply 
placed on the CAM with no restrictive measures at all.
Over 150 eggs were used in an attempt to grow thin 
versions of the Lewis lung carcinoma. Unfortunately, there 
was little success in that as the tumours grew, the CAM gave 
way under the weight of the implant, thus allowing the 
normal spherical growth of the neoplasm to occur.
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Fig. 25 _
Vascular bed of the CAM of a chick embryo through a window 
cut in the shell. A small volume of 3LL tumour mash was 
placed on, or close to, a vessel. Over the implant was 
placed a plexiglass diffusion chamber ring with a coverslip 
cemented to the upper surface.
#
Fig. 26
The vascular architecture of a 3LL tumour grown by this method
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Some degree of uniformity of tumour development could 
be achieved but not enough to permit conclusions concerning 
the vasculature of the Lewis lung carcinoma (Fig.26).
63
SECTION III
The measurement of blood flow in 3LL 
tumours after treatment with ICRF 159.
The following two techniques were used:
1) Macroaggregates of human serum 
albumin - MAA 1^31 (Flohr (1968) 
and Flohr and Hoppe (1969))
2) The distribution of Rb^^ (Sapirstein) 
(1958)
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INTRODUCTION
Blood flow to tumours
Literature dealing with tumour blood flow and circulation 
was sparse until the advent of various isotope techniques.
Most of the early workers used techniques involving the 
systemic injection of dyes. In 1916 Weil noted that certain 
dyes, such as congo red, remained in the necrotic centre of 
the tumour after the dye had been excreted from the rest of 
the body.
Other workers, Karczag e_t ^  (1920J and Engel (1925) 
injected dyes, such as lissamine green and trypan blue, 
subcutaneously into tumour bearing animals and observed a 
slight colouration of the peripheral zone of the tumour.
Duran-Reynals (1939) obtained similar results using Evans 
blue which was absent from the necrotic centre. This was 
also the case in some human tumours as reported by Brunschwig 
et al (1940).
A more careful study of the distribution of Evans Blue 
and other dyes was performed by Zahl and Waters (1941) 
using the SI80 and a mammary carcinoma. They observed an 
initial diffuse staining of the peripheral stroma and a 
more intense staining of a thin layer of semi-necrotic cells 
on the border bett\7een the viable and necrotic zones of the 
tumour.
Goldacre and Sylven (1959 and 1962) and Owen (1960) 
used lissamine green to map out areas of tumours not supplied 
by blood. These regions suddenly appeared in tumours at a
65
critical age, which in the transplanted mouse tumours 
studied (mammary carcinoma, sarcoma 37, Ehrlich-landschutz 
solid ascites) was about 12 days, and in the rat Walker 
carcinosarcoma about 5 to 10 days depending on the type 
of host. These unstained zones contained living cells, 
as demonstrated by vital staining, tissue culture and 
particularly by transplantation into new hosts. In forty- 
one transplantations from these unstained zones, twenty- 
three typical tumours were produced.
Bierman je_t aT (1951 and 1952), measuring the rate of 
blood flow to human tumours, showed that when fluorescent 
dyes were injected intra-arterially into patients with 
skin tumours the dyes appeared, under U.V. light, more 
rapidly in the primary skin tumours than in normal adjacent 
tissue. They also found that the oxygen content and 
saturation of the venous blood draining several human 
neoplasms was higher than the venous oxygen content obtained 
elsewhere, i.e. the differences in oxygen content between 
the afferent and efferent tumour vessels were smaller than 
the A-V differences found for normal tissues. They 
concluded that there was considerable A-V shunting within 
the tumour, and a greater blood flow through these tumours 
than in comparable normal tissue.
Other workers, however, have described a low tumour 
blood flow in comparison with normal tissue (Bergentz e_t al, 
1963; Gullino and Grantham, 1961; Cataland e_t aT, 1962; 
Peterson e_t 1969).
Gullino and Grantham (1961) devised an ingenious method 
to measure directly blood flow in rat tumours, * An ovary or 
kidney was displaced into a subcutaneous .position, leaving 
the vascular pedicle intact. A tumour was then implanted
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into the organ which was enveloped in a paraffin sac and 
replaced in a pouch of subcutaneous tissue. The tumour in 
the host organ was thus completely isolated from the 
surrounding tissues. The blood flow was measured directly, 
after cannulating the single vein draining the tumour, which 
eventually destroyed the host organ. They also employed an 
indirect method based on the fractional distribution of 
radioactive potassium and rubidium. There was good 
correlation in the results from both methods. They 
concluded that the blood flow of the various rat tumours 
studied followed a uniform pattern independent of histological 
type, size of tumour and site of implantation, and that the 
blood flow of these tumours was unusually low, i.e. a hepatoma 
had a blood flow about one twentieth that of the host liver 
on a gram for gram basis.
Of all the techniques that have been used to study blood 
flow in various vascular beds, (Kramer, 1963), only indirect 
methods can be employed with small animal tumours unless one 
uses Gullino and Grantham’s tissue-isolated tumours.
Sapirstein (1958) devised a method for measuring 
capillary blood flow by the fractional uptake of two highly 
diffusible ions, K^^ and Rb^^, for which the cells act as a 
kind of "sink". Sapirstein demonstrated that after a single, 
rapid, intravenous injection of either Rb^^Cl or K^^Cl, 
the isotope was distributed initially to the organs in 
proportion to their blood flow and then was carried away by 
the venous drainage. For a certain period, however, the 
amount of Rb^^ or K^^ removed by the venous drainage was 
negligible compared to that delivered by the artery. This 
period was longest for ions, such as Rb^^, which were rapidly 
transferred from the vascular system to the tissues and which 
had a large volume of distribution within the tissue.
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After intravenous injection, the or
concentration:time relationship for all organs except the 
brain showed a steep rise during the first 10 to 15 seconds, 
was steady between 20 and 60 seconds and was variable beyond 
a minute.
The plateau of the curve was interpreted as an 
indication that the amount of isotope found in each organ 
was approximately the amount brought by the blood flow. It 
was therefore possible to estimate the fractional distribution 
of the cardiac output by determining the amount of isotope in 
various organs, providing the animal was killed within 1 
minute of the intravenous injection of isotope.
This technique was applied by Cataland ^  ^  (1962) for 
the measurement of blood flow in two transplanted mouse 
tumours, the mammary carcinoma 755 and sarcoma 180. They 
observed an inverse relationship bet^^een tumour blood flow 
and tumour size. This relationship was explained by the 
development of a central unvascularized necrotic zone in the 
tumour which increased the tumour mass but not the tumour 
capillary bed. Two disadvantages of this technique were that 
the cardiac output must be known in order to express flow in 
terms of ml/min and that the animals must be killed to 
determine tumour blood flow.
The clearance technique using radioactive inert gases 
to measure capillary blood flow avoided these disadvantages 
and has been employed to measure tumour blood flow. Gump . 
and White (1968) used the clearance of radioactive krypton
q c
( Kr) to measure the blood flow of transplanted V2 
carcinomas in rabbits. Gelin e_t aT (1968) measured the 
clearance of Xe^^3 from metastatic tumours in human livers.
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Peterson ejt _al (1969) used the clearance of two locally 
injected radioisotopes, ^^^Xe and ^^Na, to measure capillary 
blood flow of two mouse tumours - mammary carcinoma and 
20-methylcholanthrene sarcoma. A recent paper by Kallmann 
et al (1972) reported the measurement of blood flow in 
irradiated mouse KHT sarcomas by clearance of Xe and found 
that anaesthesia significantly lowered the rate of tumour 
blood floif.
Many papers have described the use of radioactive 
particles, which do not pass through the systemic capillaries, 
for the measurement of regional blood flow (Grady e_t 1963;
Neutze e_t 1968). The introduction of this type of
indicator has made it possible to study the distribution of 
cardiac output directly and has facilitated the determination 
of blood flow to various organs and tumours. The principle 
was to inject a calibrated amount of indicator into the left 
ventricle, then the indicator was distributed throughout the 
body in proportion to the distribution of cardiac output, 
providing the indicator has dispersed homogenously in the 
aortic blood. Shibita and Maclean (1966) studied the blood 
flow of fourteen human malignant tumours using radioactive 
Yttrium^^ microspheres (35 t 5p in diameter) and found poor 
blood flow to the tumours.
Muller and Rossier (1951) first devised a new approach 
using radioactive microspheres that can be localised at 
selected sites for tumour therapy thus minimising radiation 
damage in healthy tissue. The microspheres were injected 
on the arterial side of the "host" organ and were trapped in 
the capillaries of the organ and tumour. Variable results 
have been reported using this technique for tumour therapy 
(Grady et al, 1960, 1962 and 1963; Ariel, 1962; Lafave e^ al,
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1963; Ya ^  1961; Perry e_t 1962). Not all the
microspheres will be trapped in the tumour. A small amount 
of radioactive material will pass through A-V shunts for 
recirculation (Prinzmetal e_t 1948; Flohr, 1968). 
Therefore, when specific doses of radiation are required 
for tumour treatment, an allowance must be made for the 
number of microspheres passing through A-V shunts.
1 qi
Flohr (1968) and Flohr and Hoppe (1969) used Iodine 
labelled macroaggregates of serum albumin (5-50|a in 
diameter) in place of microspheres to determine blood flow 
within organs of cats, dogs and rabbits by means of auto­
radiography. The radioactively labelled particles were 
injected into the left ventricle and mixed with arterial 
blood. The particles were carried via the systemic 
circulation to the various organs in proportion to the 
distribution of cardiac output. Any particles not trapped 
in the various capillary beds were transferred to the venous 
blood and eventually sequestered in the lungs. The animals 
were killed and various organs rapidly excised and frozen. 
Thick frozen sections were exposed on X-ray film.
Macroaggregates have provided a cheaper alternative to 
microspheres whilst exhibiting the same properties, i.e. 
there is a high extraction ratio of the macroaggregates as 
shown in rabbits, with only 2-3% being recirculated. Also, 
Tow e_C aT (1966) showed that these particles dispersed 
homogenously in flowing blood, which was essential for the 
validity of this technique.
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MATERIALS AND METHODS
In this section, two methods are used to measure rate of 
blood flow in control and ICRE 159 treated tumours,
1311 Determination of blood flow in 3LL tumours using Iodine 
labelled macroaggregates of human serum albumin. (The 
technique of Flohr (1968) and Flohr and Hoppe (1969)).
1 31
Details of MAA (1 ):
Radioactive concentration 0.2m Ci/ml
Specific activity ^ I m  Ci/mg protein
Protein concentration ^0.2mg/ml
Half life 8 days
Sterile suspension of macroaggregates of iodinated human 
serum albumin containing 1% benzyl alcohol made isotonic with 
NaCl.
Diameter of particles 15-50 microns.(up to 3-4% is less 
than 15p in diameter).
Seventy mice with tumours ranging from 10-15 days were used 
in these determinations.
1 310.2ml MAA (1 ) was injected retrogradely down the ligated
left carotid artery of control and treated mice anaesthetised 
with 0.2ml Avertin i.p.
The mice were kept warm, and all wounds were kept covered 
with cotton wool pads soaked in warm saline to minimise heat loss
The mice were killed within 20 seconds of the injection and 
the. tumours and kidneys were rapidly excised. •
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For quantitative evaluation the tumours and kidneys 
were counted with a well-type automatic crystal counter - 
Nuclear Enterprises NE8311.
As it was not possible to inject the same concentration 
131of MAA (1 ) into each animal, the tumour macroaggregate
concentration was expressed as a fraction of the kidney 
macroaggregate concentration. This assumed that the kidney 
blood flow remained fairly constant under experimental 
conditions.
A blood sample was taken from each animal to ensure the 
absence of circulating aggregates.
For qualitative evaluation both thick frozen sections 
(/—lOOOji) and thin histological sections (5p) were cut from 
the tumours and kidneys. Sections were placed on dental 
X-ray film or Kodak X-ray film for varying exposure times. 
The films were developed and compared with the original 
sections.
(a) To determine the effect of the anaesthetic - Avertin -
on the blood pressure of C57B1 mice and its possible
131relevance to the MAA (1 ) technique.
As will be discussed, any variation in blood pressure 
could be critical, when macroaggregates are used, for the 
measurement of tumour blood flow. Consequently, experiments 
were performed to see if the anaesthetic used in the 
macroaggregate technique caused a fall in blood pressure of 
the mice.
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Sixteen G57B1 mice, weighing between 18 and 22 grams 
were anaesthetised with 0.2ml Avertin intraperitoneally.
The left carotid artery was cannulated and the blood pressure 
was recorded with a Devices M2 pen recorder.
The cannula was filled with heparinized saline to 
prevent clotting. Blood pressure recordings were taken up to 
1 hour after the injection of the anaesthetic.
The effect of Avertin on the blood pressure of C57B1 
mice was compared with that of two other anaesthetics.
Halothane (Fluothane) in 95% O2 , 5% CO2 and Nembutal (Sodium 
pentobarbitone). 0.2ml 10% Nembutal was injected intra­
peritoneally into eight mice. The gas Fluothane was 
administered to four mice using a special nose piece. The 
blood pressure was recorded as before.
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Determination of 3LL blood flow using the techniques 
of Sapirstein (1958) with Rb^^Cl.
For these studies, experimental mice received ICRF 159 
20mg/kg suspended in 0.2ml of carboxymethyl cellulose (0.5%) 
in isotonic saline (CMC) given i.p. daily. Control mice 
received 0.2ml of CMC alone i.p. daily.
This minimised T/C values and produced the same angio­
me tamorphic effect on the 3LL tumour blood vessels.
(i) Tissue concentration of isotope:time relationship in 
3LL after intravenous injection of Rb^^Cl, and determination 
of killing time for part ii.
A dose of 2pc of Rb^^Cl in 0.2ml saline was rapidly 
injected into the tail veins of 20 control and 19 treated 
mice bearing 10 day old 3LL tumours. Mice from each group 
were killed at 5, 10, 20, 40 and 60 seconds after injection 
by dropping them into liquid nitrogen. After thawing, the 
tumour, kidneys, spleen and liver were excised. The isotope 
content of the bodies and excised organs was measured with a 
well-type automatic crystal counter.
(ii) Blood flow measurements of control and treated 3LL tumours
A dose of 2yic of Rb^^Cl in 0.2ml saline was rapidly 
injected into the tail veins of 45 control mice and 43 treated 
mice bearing tumours ranging from 7-21 days old. All mice 
were killed at 40 seconds after injection by dropping them in 
liquid nitrogen. After thawing, the tumour, kidneys, spleen, 
liver, lungs, stomach and intestines, and the carcass were 
counted as before. The older tumours were divided into viable 
and necrotic zones and counted separately.
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As the cardiac output has not been measured, the flow 
values cannot be expressed in terras of ml/minutes/gm of 
tumour. The values for the tumours and various organs were 
therefore expressed as percentage of injected dose.
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RESULTS
MAA
The quantitative values of 3LL tumour blood flow using 
the technique of Flohr (1963) and Flohr and Hoppe (1969) 
were extremely variable for both control and treated animals. 
There was no significant difference in the values for control 
and treated tumours (Table 2).
There was virtually no activity in the blood samples 
taken from each animal, demonstrating the absence of particles 
in the circulating blood.
A significant finding was the difference in the macro­
aggregate concentration found in the right and left kidneys 
from each animal. 81.5% of control and treated animals 
demonstrated a higher macroaggregate content in the right 
kidney. The magnitude of the difference between right and 
left kidney was as much as 3X.
Fig.27 shows the intratumoural particle distribution, 
in six thick frozen sections, but because of the lack of 
detail and the difficulty of keeping the frozen sections on 
the dental X-ray films, thin sections were cut for most of 
the tumours.
Figs.28 & 29 show the particle distribution in thin 
histological sections of tumours and kidneys from control 
and treated animals.
Blood flow distribution was confined to the cortex of 
the kidneys. Flohr and Hoppe (1969), using this technique, 
were able to distinguish three distinct compartments of
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Fig. 27
Macroaggregate distribution in thick frozen sections of 
control (3 & 4) and treated (1 & 2) 3LL tumours.
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Fig. 28. Macroaggregate distribution in thin histological 
sections cut from the central segment of a large 11 day control 
3LL tumour. Sections of the kidneys from the same animal are 
also shown. Sections were placed on Kodak X-ray film for an 
exposure time of 3 hours. Note that in both the tumour and 
kidney sections, the macroaggregate distribution is confined only 
to the outer cortex.
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Fig. 29
Macroaggregate distribution in thin histological sections cut 
from some 11 day treated 3LL tumours. Sections of the kidneys 
from one mouse are also shown. Exposure time was 3 hours.
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blood flow within the cortex of kidney sections taken from 
dogs. Any variation of particle distribution within the 
cortex was not discernible because of the size of the 
mouse kidneys.
As demonstrated with lissamine green, the particle 
distribution within the tumour was confined to an outer 
cortex, with no activity found in the middle of the tumour. 
This indicates an absence of functional blood vessels of 
the order l5-50|i in diameter within this region.
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The effect of anaesthesia on the blood pressures and heart 
rates of C57B1 mice
Table 3 shows the effect of Avertin, Nembutal and Halothane 
on the heart rates and blood pressures of C57B1 mice.
TABLE 3
Anaesthetic - route administered Mean heart rate
and range -
Avertin
Nembutal
Halothane
X. p.
i.p.
inhalation
beats/min.
450 (330-570) 
480 (420-540) 
420 (360-570)
Mean b.p. and 
range mm.Hg.
77 (64-94) 
66 (57-76) 
68 (57-89)
The values obtained for the heart rate and blood pressure 
were markedly lower than those quoted for unanaesthetised mice, 
(Table 4).
The blood pressure was recorded on average 15 minutes
after injection of Avertin, i.e. a comparable state of
131anaesthesia existed in the mice injected with MAA (1 ).
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TABLE 4
Blood pressures and pulse rates of unanaesthetised mice
Strain of 
mice
Pulse rate/min.
(mean ^ S.E.)
 .Systolic b.p.
mnLHg. (mean S.E.)
Reference
A
AJ male
BALB/eJ
male
CBA/J male 
CBA male 
CBA male 
CBA male 
C3H
C3H
C3H
C57/B1/6J
male
DBA/2J
male
RF/J male 
SJL/J male 
129/J male
107.8 i 1.8
83.9 t 1.7
104.9 - 1.7
97.4 t 1.9
103 + 6
111 (95 to 138)
136 (114 to 165:
151 (138 to 164:
93.3 t 2.2
89.4 ± 2.0
96.0 t 1.8
96.0 t 2.0
88. 7 t 2.0
589 t 11
494 t 11
657 t 8
633 t 11
614 t 11
595 t 11
639 Î 14
630 t 8
Edwards and 
Reinecke (1953)
Schlager (1965)
Henry et aH (1963)
Wu and Visscher 
(1947)
Schlager (1965)
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RbBGci
(i) Table 5 shows the amount of Rb^^ found in 3LL control 
and treated tumours and various organs of C57B1 mice at 
varying times after single intravenous injections of Rb^^Cl 
Each value (% of injected dose) represents the average of 
3-5 mice.
In general, the organs and tumours showed a continued 
accumulation of Rb for the first 5-20 seconds. The 
concentration of Rb^^ then reached a plateau although there 
was some variation up to 60 seconds.
The killing time of 40 seconds after injection of the 
isotope was chosen as this fell midway along the Rb^^ 
concentration plateau. The assumption was made that the 
percentage of injected material in the tumours and organs 
corresponded to the percentage of distribution of the cardiac 
output.
(ii) There was no significant difference between the Rb^^ 
content per gram of control and treated tumours of different 
ages (Fig.30). However, there was a progressively lower 
fractional uptake of indicator per gram of tissue as the 
tumours increased in size (Fig.31). There was also a 
progressive diminution in the uptake of Rb^G per gram of 
tumour when the central necrotic tissue was removed and only 
the outer viable cortex counted. Removing the necrotic 
tissue made no difference to the blood flow values except in 
the oldest tumours (Fig.32). The percentage of injected dose 
of Rb^^ (i.e. the percentage of the cardiac output) reaching 
control and treated tumours in toto increased from 1-5% 
between the 7th and 21st day (Table 6).
84
TABLE 5
Amount of in the tumour and various organs of
C57B1 mice at different intervals after a single, rapid, 
intravenous injection of Rb Cl.
Each value (% of injected dose) represents the average 
of 3 - 5 mice.
CONTROL
Time sec. 
5 
10 
20 
40 
60
Tumour
2.15
2.21
1.73 
1.94 
1.50
Kidney
2.90
3.95
6.30
4.80
3.39
Spleen
1.27
1.49
1.72
1.77
1.19
Liver
8.76
9.50
8.60
8.31
7.47
EXPERIMENTAL
5
10
20
40
60
2.68
2.27
1.84
1.93
2.65
5.23
5.90
4.20
3.60
3.38
0.98
1.78
1.35
1.19
1.25
12.63
11.61
9.09
8.50
10.28
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TABLE 6
Amount of in tumours of various ages and organs
after a single, rapid, intravenous injection of Rb^^Cl.
Each value (% of injected dose) represents the average 
of 5 - 7 mice. All mice killed at 40 seconds after 
injection.
CONTROL
of Tumour 
Day
T K Sp L St & Int
7 0. 80 3.33 1.41 8.43 15.78
9 1.11 4.31 1.42 7. 70 15.20
11 2.74 5.29 2.11 8.92 17.99
13 3.98 4.92 1.11 7.63 18.31
15 3.08 7.85 1.73 7.78 17.97
17 3.94 4.67 1.24 8.51 16.17
21 5.44 8.09 1.88 8.74 20.84
EXPERIMENTAL
7 0.91 3.26 1.25 8.85 16.71
9 1.33 2.53 1.01 8.42 13.78
11 2.53 4.67 1.37 8.55 16.93
13 3.02 7.60 1.45 7.89 20.50
15 3.38 6.32 1.53 9.81 20.68
17 4.65 5.17 1.03 8.63 17.21
21 4.86 4.66 1.65 8.59 19.43
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The spleens, livers, and stomach and intestines
of control and treated tumours showed a stable content of 
Rb^G throughout the whole experiment. Kidney values were 
low and extremely variable (Table 6).
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DISCUSSION
Shibata and Maclean (1962) suggested that one of the 
main factors affecting chemotherapeutic treatment of cancer 
was the impaired blood flow to the primary tumours. Chemo­
therapeutic agents, to be effective against the tumour, 
have to be administered in ever increasing doses, which 
obviously affects detrimentally the host as well as the 
tumour.
Specific alterations in the morphology of tumour blood 
vessels could have considerable consequences for the treat­
ment of neoplasms, in that the blood flŒ>7 rates in tumours 
of animals treated with ICRF 159 may be higher than normal 
and consequently the .availability of anticancer drugs might 
be increased. It was thought that this consideration might 
explain the greater effectiveness of other anticancer drugs 
when used in combination with ICRF 159 - Hellmann and 
Burrage (1970); Woodman e_t ^  (1971).
The present study however has failed to demonstrate a 
significant effect of ICRF 159 on 3LL tumour blood flow, as 
determined by the techniques of Sapirstein (1958) and Flohr 
(1968) and Flohr and Hoppe (1969).
Certain aspects of these results require clarification.
131
(1) The distribution of particles of MAA (1 ) within the
tumours was detected by the autoradiographs and confirmed 
the earlier work with lissamine green, in showing that the 
blood flow distribution in both control and treated tumours 
was confined to an outer zone or cortex which encapsulated 
the tumours. There was no blood flow in necrotic centres of 
the tumours as demonstrated by these techniques.
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The quantitative values for 3LL blood flow using 
131MAA (1 ) are not easy to interpret as the results were
extremely variable. No significant difference was observed 
betx\7een control and treated tumours. The technique, in 
principle is simple, and, as reviewed in the introduction, 
the method has been employed with great success for organ 
blood flow measurements in animals larger than mice.
However, when one is dealing with mice, especially sick 
mice, the technique must be viewed with caution. The isolation 
of, and injection down the carotid artery is time consuming 
and difficult, and although the conditions are kept as stable 
as possible there must be great variations in the systemic 
blood pressure and blood flow to the various mouse organs.
(2) An essential prerequisite for the validity of the 
macroaggregate technique is that the particles are homogenously 
dispersed in the aortic blood so that distribution of the 
label will be in proportion to the cardiac output. The 
observation that 81.5% of control and treated animals 
demonstrated a higher macroaggregate content in the right 
kidney as opposed to the left, suggests that the injected 
particles are not dispersing homogenously in the blood 
leaving the heart.
(3) Another aspect of the technique that calls for comment 
is the effect of anaesthesia on the blood pressure of tumour 
bearing animals. Algire and Legallais (1951), using the 
transparent chamber technique, demonstrated that the tumour 
blood flow was decreased by lowering the peripheral blood 
pressure. The reduction of tumour circulation was directly 
correlated with the duration and degree of peripheral 
hypotension. These workers induced hypotension in several 
ways: by i.p. injections of histamine or hypertonic glucose.
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by shock following the release of tourniquets, or by local 
mechanical obstructions to arterial flow.
Also, Kallmann e_t al (1972), using the xenon clearance 
method with KHT sarcomas in C3H mice, demonstrated that the 
state of anaesthesia lowered the systemic blood pressure 
and consequently decreased the rate of tumour blood flow.
The blood pressure values of C57B1 mice, as recorded 
from the carotid artery, were certainly lower than those 
obtained from the literature where indirect measuring 
techniques were used. All the three anaesthetics tried, 
produced a similar fall in blood pressure. Thus, from these 
results and from observations found in the literature, it 
would be expected that any agent or condition, such as the 
state of anaesthesia, that reduced the blood pressure in the 
arteries supplying a tumour would similarly interfere with 
the circulation within the tumour. Because of these findings, 
and the uncertainty of achieving reproducible levels of 
anaesthesia in the mice, a technique was used which involved 
no surgery and therefore no anaesthetic. Such a technique 
is that described by Sapirstein (1958).
(4) The distribution of blood flow in mice was measured by 
the fractionation technique for tumours and organs using 
Rb . This method depends on the fact that tumours and all 
organs, other than the brain, have virtually the same 
extraction ratio of Rb^^ as the whole body during the first 
minute after a single intravenous injection of Rb^^. Thus, 
the uptake of the isotope by any organ during the first 
minute will be related to the total body uptake as is that 
organ's blood flow to the cardiac output.
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To apply Sapirstein's method to the determination of 
control and treated 3LL blood flow, it was first necessary 
to determine whether the concentration : time relationship 
in the neoplastic tissue reached a plateau as in normal 
organs, as had been shown by Sapirstein (1958); Gullino and 
Grantham (1961) and Fowler e_t ^ (1972), These workers 
confirmed the existence of a plateau in Rb®^ uptake between 
15 and 60 seconds, indicating that the amount of isotope 
found in each organ was approximately that brought by the 
blood flow.
In a pilot study, the time : concentration relationships 
for 3LL tumours and various organs showed agreement with the 
results obtained by the above workers, and so a similar 
killing time of 40 seconds was chosen as this fell in the 
middle of the concentration:time plateau. The assumption 
was made that the amount of isotope found in the various 
organs and tumours at 40 seconds corresponded to the 
distribution of the cardiac output.
Although there was no significant difference between 
the amounts of Rb found in control and treated 3LL tumours, 
there was fair agreement with the values obtained for various 
mouse tumours, as reported by Gullino and Grantham (1961) - 
Table 7.
Also, despite great variance in species, size of 
different animals, tissues studied and experimental tech­
niques, the values obtained for blood flow to the various 
organs were similar to those found in other reports - Table 8,
Only the values obtained for kidney blood flow were 
markedly different from expected physiological values.
Gullino and Grantham (1961) suggested that anaemia probably
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TABLE 7
Amounts of found in mouse tumours
Tumour Av. wt. 
gm.
% injected dose of Rb 
Range gm. Av. value Range
86
Hepatoma 
Os teogenic
2.5 0.3 - 5.2 3.00 0.36 - 6.24
sarcoma 2.8 0.5 - 3.5 2.24 0.40 - 2.80
Histiocytoma 1.5 0.2 - 2.5 3. 75 0.50 - 6.25
3LL control 1.0 0.1 - 2.9 3.01 0.43 - 8.51
3LL treated 0.9 0.1 - 2.4 2.95 0.47 - 7.17
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caused the low values for kidney blood flow in their 
experiments and cite two references, Bradley and Bradley 
(1947) and Whitaker (1956), in support of this premise.
With the Lewis lung carcinoma, however, two considerations 
have to be made with regard to kidney blood flow. Firstly, 
the mice used in these experiments - C57B1 - are susceptible 
to hydronephrosis, Cotchin and Roe (1967), Although the 
kidneys of control and treated mice appeared normal in size 
and shape, it is possible that early stages of this 
pathological condition exist, with a resulting decrease in 
kidney blood flow. Secondly, X-ray arteriography has indicated 
that one of the vessels supplying the 3LL tumour arises from . 
the area of the renal artery. Whether this vessel acts as a 
shunt for some of the renal blood flow is debatable. As 
Sapirstein concluded, there is no explanation for the low 
kidney values.
(5) One of the major differences between these experiments 
and those previously reviewed, is the technique for killing 
experimental mice. Sapirstein (1958) and Gullino and 
Grantham (1961) killed the animals by cutting through the 
thorax just below the axillae with a mallet driven axe. The 
timing was accurate to ^ 1 second. Cataland ^  ^  (1962) 
decapitated the animals. Both techniques however, would not 
stop blood flow immediately as the heart would still pump 
out blood for many seconds. This could be critical for 
concentration : time curves especially when the readings were 
taken at 3, 6, 9 and 12 seconds in Sapirstein’s paper; at 
2, 5 and 10 seconds in Gullino and Grantham's paper; and at 
20 seconds in Cataland's paper. The killing technique 
employed in these experiments, i.e. dropping the animals into 
liquid nitrogen, is likely to arrest the circulation 
sufficiently rapidly to avoid the above criticism.
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(6) Many workers, using a variety of tumours and techniques, 
have demonstrated an inverse relationship between tumour 
blood flow and tumour size - Gullino and Grantham (1961) ; 
Cataland al (1962) ; Summers (1966); Vogel and Haynes 
(1966) ; Robert e_t al (1967) ; Rogers 2Ë (1969) ; Song and 
Levitt (1971); Kallman e_t ah (1972) and Fowler e_t ^  (1972). 
This observation was explained in the papers of Cataland e_t 
al (1962) and Rogers e_t al (1969) , by the development of 
central unvascularized necroses during tumour growth. The 
growth of the tumour vascular bed did not keep pace with 
tumour growth as a whole, giving rise to an inverse 
relationship between blood flow and tumour size. This is 
not the case with the 3LL tumours because there is still a 
decrease in blood flow even if the necrotic centre is removed 
and only the outer viable cortex is counted. Also, as Jirtle 
and Clifton (1973) suggested, the inclusion of any non-viable 
tissue, especially in large tumours, is likely to be a 
fundamental error in any calculations of tumour blood flow.
(7) It is important to note that both the macroaggregate 
and Rb^^ techniques measure only functional rather than total 
blood flow to the tumour. Blood flow through arteriovenous 
shunts and other non-exchanging areas is not measured. Thus, 
any isotope carried by the shunted blood will be redistributed, 
and in the case of Rb^^, to the exchanging areas giving 
slightly higher values for the fractional uptake of indicator 
than their true fraction of the cardiac output. Any macro­
aggregate passing through arteriovenous shunts will be trapped 
in the capillary beds of the lungs. The amount of shunting 
that occurs in 3LL tumours has not, as yet, been measured.
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SECTION IV
The effect of serotonin on 3LL tumours 
after treatment with ICRF 159.
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INTRODUCTION
Cater e_t al^  (1962) and Cater e_t ^  (1966) measured 
blood flow changes in rat and mouse tumours by means of 
oxygen tension measurements and the response to oxygen 
inhalation after the injection of various vasoactive drugs. 
Tumour oxygen tensions were measured with microelectrodes 
inserted into the tumours. They found that tumour blood 
flow varied directly with systemic blood pressures except 
after the injection of physiological amines, in particular 
serotonin. These workers demonstrated that serotonin 
profoundly decreased tumour blood flow at doses which had 
little or no effect on muscle oxygen tensions and produced 
only a slight fall in the systemic blood pressure. If the 
systemic blood pressure was low, serotonin tended to raise 
it, and in spite of this, the tumour oxygen tension still 
fell. They pointed out that serotonin had a specific action 
on tumours, as anti-serotonin drugs (e.g. 1-methyl-lysergic 
acid butanolamide) given prior to serotonin reduced or 
prevented the effect on tumour blood flow. When anti­
serotonin drugs were administered after serotonin, the effect 
was reversed.
Using the same technique, Cater e_t al (1963) demonstrated 
that serotonin actually stopped tumour blood flow, since the 
inhalation of oxygen at 5 atmospheres absolute failed to 
produce a rise in tumour oxygen tension.
Cater and Taylor (1966) suggested several possible 
explanations for the abnormal sensitivity of tumour blood 
vessels to serotonin:-
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1. Newly-formed tumour vessels could simply be particularly 
sensitive to serotonin as is the case with the tips of new 
capillary buds, Schoefl (1964). Alternatively the sensitivity 
of tumour vessels to serotonin could be due to anatomical 
defects, perhaps produced as a direct result of their rapid 
formation.
2. The poor blood flow of tumours might account for the 
effect in that this would allow time for the serotonin to 
become localised. Also, a sluggish blood flow would result 
in low oxygen tensions, which in turn would inhibit the 
activity of the enzyme - mono-amine oxidase - and consequently 
lead to an accumulation of serotonin within the tumour.
3. It is possible that many of the tumour blood vessels are 
already partially inflamed because of their close proximity 
to necrotic areas, and therefore only very small doses of 
serotonin need be injected to affect these vessels. Cater 
and Taylor (1966) demonstrated this point by injecting Pelikan 
ink (colloidal carbon which labels inflamed vessels as 
described in Section II) i.v. into rats transplanted with 
hepatomas followed by an injection i.p. of either serotonin
or saline. The tumours of rats injected with saline showed 
labelled vessels near zones of necrosis, whereas in rats 
injected with serotonin not only was there an increase in the 
labelling of vessels near necrotic areas, but a number of 
vessels in the viable parts of the tumour were also labelled.
4. It is known that subcutaneous injections of serotonin 
will cause marked local oedema. Cater e_t al^  (1962) thought 
that tumours with their higher than normal tissue fluid 
pressures would be abnormally sensitive to serotonin in that 
it might increase tissue oedema to the point of blocking the 
circulation.
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The effect of serotonin on tumours was further 
investigated by Goldacre and Dayal (1969) and Dayal (1970) 
using lissamine green to map out tumour zones not reached 
by blood-borne dyes. Serotonin, injected i.p., caused 
existing uncoloured zones in large tumours to extend even 
further in transplanted Walker, Crocker and ADJ-PC-6A 
tumours, so that only a very thin cortex at the periphery of 
the tumours was coloured green. One tumour, however, the 
Gardner lymphosarcoma, was unaffected by serotonin, even 
after multiple injections of the agent - the tumour appearing 
green throughout. These workers suggested that the difference 
in response to serotonin was due to the vascular arrangements 
within these tumours. The vessels of the Walker, Crocker and 
ADJ-PC-6A appeared to be newly-formed, whereas the Gardner 
lymphosarcoma appeared to be vascularized by the appropriation 
of pre-existing normal vessels.
On the basis of these results, the effect of serotonin 
can be used as a test for the normal 'character' of tumour 
blood vessels. Consequently, the effect of serotonin on 
control and ICRF 159 treated 3LL tumours was tested and the 
results discussed in relation to the theoretical mechanisms 
of the action of serotonin.
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MATERIALS AND METHODS
Forty C5 7B1 mice bearing tumours ranging from 10 - 15 
days old were used in these experiments. Control or treated 
mice were injected either with 0.1ml saline or 0.Irai serotonin 
(5mg base/kg of 5 hydroxytryptamine creatine sulphate in 
saline) intraperitoneally, Cater e_t ^  (1962).
After 20 minutes, 0.3ml of lissamine green was injected 
into the tail vein. The mice were killed 5 minutes later 
and the tumours bisected.
With some mice the tumours were exposed after i.p. 
injection of serotonin. Then Indian ink instead of lissamine 
green was injected i.v. and the tumours observed under a 
dissecting microscope.
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RESULTS
The action of serotonin on control and ICRF 159 treated 
3LL tumours is demonstrated in Figs.33 & 34.
Areas of control tumours not reached by lissamine green 
were much larger after the injection of a single dose of 
serotonin. The unstained areas extended over most of the 
tumour leaving only a very thin green zone at the periphery 
of the tumour (Fig.33). If saline instead of serotonin was 
injected i.p., only the necrotic area of the tumour remained 
uncoloured, as previously described in Section II.
With treated tumours, however, no serotonin effect was 
shown (Fig.34), even if a second dose of the agent was 
injected 30 minutes after the first. The tumours were 
coloured throughout, except for the central necrotic areas.
This was also the picture for treated tumours when saline 
was injected in place of serotonin.
When Indian ink was injected in place of lissamine green, 
the tumours demonstrated the same response to serotonin. The 
ink filled the host vessels surrounding control tumours, but 
not until the effect of serotonin started to wear off (10 to 
20 mins. after injection of serotonin) did the ink penetrate 
the tumour vessels. After 1 hour all the control tumour 
vessels were filled with ink.
Serotonin had no effect on treated tumours in that all 
the vessels appeared black straight after the ink was 
injected. This also occurred in control and treated tumours 
where saline was administered as a control for- serotonin.
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Fig. 33
Effect of serotonin on 10 day control 3LL tumour. Note the 
large unstained zone due to serotonin.
Fig. 34
No serotonin effect on a 10 day 3LL tumour after treatment 
with ICRF 159.
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DISCUSSION
Dayal (1970) and Day (1964) have both suggested that 
the difference in the response of certain tumours to serotonin 
lies in the manner of their vascularization. Tumours with 
newly-formed vessels (e.g. Walker, Crocker and ADJ-PC-6A) 
were found to be abnormally sensitive to serotonin compared 
with tumours which were vascularized by the appropriation of 
pre-existing normal vessels (e.g. Gardner lymphosarcoma).
On this basis, the observation that serotonin did not affect 
ICRF 159 treated tumours suggests that the blood vessels are 
more akin to normal blood vessels than newly-formed tumour 
blood vessels. Further, these results support the hypothesis 
of Cater and Taylor (1966) that the sensitivity of tumour 
blood vessels could be due to anatomical defects in their 
structure. The other possible mechanisms of action of 
serotonin as described by Cater and Taylor (1966) could be 
the direct result of the abnormal structure of tumour blood 
vessels.
The premise that only newly-formed tumour blood vessels are 
affected by serotonin cannot apply to the present results as 
both control and treated tumours are mainly vascularized by 
newly-formed blood vessels and therefore should both show a 
positive serotonin effect.
In Section 111 it was demonstrated that there was no 
significant difference in the blood flow values for control 
and treated 3LL tumours. Therefore the theory that a sluggish 
tumour blood flow results in a build up of serotonin again 
cannot account for the present situation. If this were so, 
then the blood vessels of treated 3LL tumours would similarly 
be affected by serotonin. Also, the blood flow results 
indicate that the theory of inhibiting the action of mono-amine 
oxidase must be viewed with caution.
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SECTION V
The vitality of 3LL cells in areas of 
control and ICRF 159 treated tumours 
devoid of functional blood vessels.
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INTRODUCTION
The subject of necrosis was reviewed in detail by 
Dayal (1970). One of the most interesting points discussed 
was the vitality of tumour cells found in necrotic areas and 
its,relevance to the poor results of chemotherapy and/or 
radiotherapy against large tumours.
Many workers have demonstrated an inverse relationship 
between size of tumour and the curative effect of chemo­
therapy. Shapiro and Fugraann (1957); Martin and Fugmann 
(1960) and Martin (1961) found that prior surgical reduction 
of large tumours significantly aided their response to 
chemotherapy. Surgery was also suggested by Larionov (1959) 
in his study of the effect of alkylating agents on different 
human neoplastic diseases. He concluded that "the degree of 
the antitumour effect is inversely proportional to the mass 
of the tumour tissue".
Radiotherapy has also been found more effective against 
small tumours. Suit ^  al (1960), using a mammary carcinoma 
in C3H mice, demonstrated that radiation in high pressures 
of oxygen produced an enhanced "cure rate" with small tumours 
(7-lOram diameter) compared with larger tumours (10-15mm 
diameter). This was also the conclusion of Scott (1953) 
using the Ehrlich ascites tumour, and the quoted results of 
Goldfeder (1960) using an adenocarcinoma.
There are several accounts as to why treatment, whether 
it be chemotherapy and/or radiotherapy, is more successful 
against small tumours. Lamerton (1972 and 1973) suggested 
that as the tumours increased in size, tumour cells would 
develop a critical resistance to the chemotherapeutic drug.
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Also, as the tumour grew, there was an increase in the 
number of slowly dividing or resting tumour "stem" cells.
It is well known that the cytotoxic action of many chemo­
therapeutic agents is directly dependent upon the rate of 
tLimour cell division. Thus any phase specific or cycle 
dependent drugs would be completely ineffective against 
these resting tumour cells.
Martin e_t ^  (1962 and 1964) suggested that with the 
larger tumours, it was the sheer number of tumour cells 
"blocking" the host defence mechanisms that diminished 
chemotherapeutic measures. Consequently, more encouraging 
results could be produced by first reducing the size of the 
tumour mass and then stimulating the defence mechanism of 
the host.
Goldacre and Sylven (1962) and Goldacre and Whisson 
(1966) suggested that it was the number of viable cells 
respiring anaerobically in necrotic areas that aided the 
re-growth of tumours following chemotherapy. These central 
necrotic regions, which were largely inaccessible to chemo­
therapeutic agents because of an absence of functional 
vessels, contained living cells as shown by transplantations 
into new hosts. These workers reported that of forty-one 
transplantations of necrotic material from sarcoma 37 and 
Walker tumours, twenty-three typical tumours were produced.
Dayal and Goldacre (1969) demonstrated that the central 
necrotic areas of the Walker tumours contained living cells 
that were not affected by the anti-tumour drug, melphalan. 
Tissue from both the peripheral well-vascularized zones 
and the central necrotic zones of Walker tumours was trans­
planted into new hosts after the donor animals had been
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treated with various doses of melphalan. The percentage of 
takes from the peripheral zones decreased with increasing 
concentrations of melphalan, whereas, the percentage of 
takes from the central zones of the same animals remained 
constant, even at toxic doses of the antitumour drug.
Similar conclusions were reached by Thomlinson (1960), 
in his paper on the synergistic effect of oxygen in the 
radiotherapy of tumours. After irradiation of large tumours 
in aerobic conditions, some tumour cells may survive in 
necrotic areas because of the protective effect of hypoxia 
and subsequently regenerate the tumour after the death and 
absorption of the radiosensitive cells. Thus, the extra 
oxygen used in radiotherapy experiments, only increased the 
radiosensitivity of tumour cells within close proximity of 
functional tumour blood vessels.
The vitality of 3LL regions from control and treated 
mice was tested using the technique of Goldacre and Whisson 
(1966) in which systemically injected lissamine green was 
used to map out the necrotic areas of the tumours. The 
results are discussed with reference to the autoradiographs ■ 
of tumour blood supply from Section 111.
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METHODS AND MATERIALS
Thirty C57B1 mice (fifteen control and fifteen treated) 
bearing tumours ranging from 10-20 days in age were injected 
i.v. with 0.3ml lissamine green. The mice were left for 
1 hour, then the tumours were excised and divided into 
stained and unstained regions. Unstained tissue within 1mm 
approximately of the viable border of the tumour was not 
included for transplantation. This excluded any viable cells 
within the limits of diffusion of essential metabolites from 
the vessels in the peripheral zone of the tumour.
Only the unstained tissue was implanted subcutaneously 
by Bashford needle into new hosts of the same strain..The 
mice were observed for positive takes. Any tumours which 
arose, were excised when approximately equivalent in size to 
21 day tumours of the routine tumour line. The lungs were 
examined for métastasés.
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RESULTS
Table 9 gives the results of forty-three transplants of 
necrotic material from control and treated 3LL tumours.
TABLE 9
Age of donor tumour (days) Positive takes/ Days after im- 
Control or Treated Number implants plantation when
tumours removed
10 Control 3/3 30
Treated 1/1 30
13 Control 1/5 54
Treated 3/4 28
15 Control 2/5 52
Treated 5/5 27
17 Control 4/5 50
Treated 1/5 50
20 Control 1/5 48
Treated 2/5 48
All but one (17 day old, 159 treated) of the mice with positive 
tumour transplants had numerous métastasés in the lungs.
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DISCUSSION
If a tumour is to be treated with chemotherapeutic 
agents, it is essential that the drugs reach all the viable 
tumour cells. This ideal is not achieved in the case of the 
Lewis lung carcinoma. The results demonstrated that the 
central necrotic zones of control and treated 3LL tumours 
contain viable cells capable of propagating growth of new 
tumours. These central areas,however, are devoid of 
functional blood vessels as shown by: (i) autoradiography
with labelled macroaggregates, and (ii) intravital staining 
with lissamine green. Consequently, viable cells in the 
necrotic centre are inaccessible to chemotherapeutic agents 
administered via the systemic circulation, unless a slow 
diffusion of the drug occurs from the viable cortex of the 
tumour. These results are in agreement with those of Goldacre 
and Sylven (1962) and Goldacre and Whisson (1966) as described 
in the introduction.
Steel (personal communication) has similarly demonstrated 
that transplants of necrotic material from 3LL tumours have 
resulted in positive takes but the interpretations differ 
widely. He describes the existence of a ’cord-like’ 
arrangement, as demonstrated in mouse tumours by Tannock
(1968), existing in the central areas of 3LL tumours. That 
is 'cords’ (radii 60-120p) of viable tissue arranged 
cylindrically about tumour blood vessels within large areas 
of necrotic tissue. Clearly, transplants from these 
supposedly necrotic areas into new hosts would result in 
re-growth of the neoplasm. The discrepancy between the two 
interpretations can be resolved however, in that Steel only 
alloi\TS the tumours to grow to 1cm in diameter -before trans­
planting central tissue into new hosts. In these
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laboratories, 3LL tumours of 1cm diameter (about 8 days old) 
are not necrotic and one would expect functional blood 
vessels and viable cells to be present in the central zone.
At this size, if lissamine green is injected i.v. the tumours 
are coloured throughout.
Whether the viable cells found in the necrotic areas of 
3LL tumours are near incipient necrosis, ("B" type cells) of 
Caspersson and Santesson (1942), has not been demonstrated. 
These cells, which are found in areas devoid of functional 
blood vessels, present a serious problem for therapy in that 
they are inaccessible to chemotherapeutic drugs and probably 
protected from radiation by hypoxia.
As Goldacre and Sylven (1962) conclude "the necrotic 
centre is an uneven dispersion of living tumour cells surviving 
almost anaerobically in a medium of autolysed tumour tissue, 
which has no blood supply and exchanges material only very 
slowly with the external living tissue".
114
SECTION VI
General Discussion
115
GENERAL DISCUSSION
In a recent paper. Reinhold (1972) stated: "Blood
vessels and microcirculation are probably not essential to 
the cause of cancer, but they are involved in so many aspects 
of tumour growth and therapy that they certainly deserve all 
our attention.
Imagine that we could influence the vascularization of 
tumours, what would we wish to do? There are two changes 
that may benefit the patient, but they are in some ways 
contradictory.
(a) During therapy we would like to see an improvement in 
the blood supply, so that all tumour cells become better 
oxygenated and therefore more radio-sensitive. In the case 
of chemotherapy, this would mean that all cells would become 
exposed to the drug.
(b) If no active therapy is performed, we would like to 
inhibit tumour growth in so far as is possible. If we could 
prohibit the induction of the vascular supply, then this would 
also arrest tumour growth". An example of this latter approach 
to tumour therapy is the work of Folkman and his group with 
the concept of anti-angiogenesis, as described in Section II.
However, it is statement (a) which is directly relevant 
to the present study for it explicitly supports the current 
reasoning behind the utilization of ICRF 159, in that if the 
drug could improve the vascularization of the tumour, this 
would facilitate both chemotherapy and radiotherapy. Although 
no significant difference was demonstrated between the blood 
flow values of control and treated 3LL tumours, the improve­
ment in the morphology and character of the tumour blood
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vessels may, in part, explain the greater effectiveness of 
other anticancer drugs when used in combination with ICRF 
159, Hellmann and Burrage (1970); Woodman e^ ad (1971). 
Similarly, this normalisation in the vasculature may account 
for the improved results of radiotherapy when given in 
combination with ICRF 159, Hellmann and Murkin (personal 
communication).
It seems unlikely that ICRF 159 is unique in its angio- 
metamorphic effect on tumour blood vessels, although a search 
of the literature has failed to reveal any such agents. More 
likely, research workers have been concerned with simply 
inhibiting tumour growth and one wonders how many of the 
apparently ineffectual cytostatic agents thrown out by drug- 
screening programmers, would have proved highly active as 
angiometamorphic drug’s. Consequently, using the 3LL as a 
model of tumour dissemination, a number of anticancer agents 
have been tested for their antimetastatic effect and their 
action, if any, on the vasculature of the primary implants, 
Hellmann e_t ad (1973).
Cyclophosphamide inhibited 3LL metastasis though only 
to an extent proportional to its inhibition of the growth of 
the primary implant; it seemed to have no angiometamorphic 
effect (Salsbury ^  1970).
Methotrexate, even at maximum tolerated doses, did not 
affect primary or secondary tumours. Similar results were 
demonstrated with Vincristine.
Prednisolone markedly inhibited the growth of the primary 
implants but did not prevent the appearance of. secondaries in 
the lungs.
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5-Fluoruracil, like ICRF 159, almost completely inhibited 
the formation of métastasés without affecting the growth of 
the primary implant. Consequently, this agent is under further 
investigation in these laboratories.
Using the same test system. Franchi e^ t al (1971) 
demonstrated that Triton WR 1339, a formaldehyde polymer of 
polyoxyethylene ether of octylphenol, inhibited the formation 
of pulmonary métastasés at doses which caused no reduction of 
weight of the primary tumour. As to its mode of action 
however, there is no similarity with ICRF 159, since Triton 
WR 1339 fails to prevent the release of 3LL cells into the 
circulation. The possible explanations for the mode of anti­
metastatic action of the agent were twofold: (i) the drug
directly inhibited the movement of cancer cells by altering 
their adhesiveness and increasing their volume, and (ii) the 
drug enhanced the host's defence mechanisms to the circulating 
cancer cells. However, these results have been criticised by 
Hellmann (1973) who showed that Triton WR 1339 did not in fact 
inhibit metastasis. Further, Carter e^ al (1971) found that 
this agent actually aided the spread of a spontaneously 
disseminating hamster lymphoma.
One of the main criticisms levelled at the introduction 
of new anticancer agents is that although they are highly 
effective against experimental tumours, their usefulness is 
limited against human neoplasms. ICRF 159 is currently 
undergoing clinical trials, but it is too early yet for 
evaluation.
From the present study, tnvo approaches to tumour therapy 
can be made: (i) At presentation many tumours have already
metastasised. With some patients, although clinically no 
métastasés can be detected, secondaries are found when more
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sensitive techniques are employed. An example of this is
that patients with early stage carcinoma of the breast often
18show métastasés when the F isotope bone scanning method 
is used, Sklaroff and Charkes (1968); Galasko £t al (1968) 
and Galasko and Doyle (1972). In these cases it is too late 
to test for the antimetastatic effect of ICRF 159. However, 
the angiometamorphic effect on the primary and secondaries 
with subsequent radiotherapy or chemotherapy could be evaluated, 
(ii) The second approach concerns patients with tumours which 
are non-resectable by surgical criteria but are still in a 
relatively early stage with no métastasés e.g. some patients 
with carcinoma of the bronchus. In this case, ICRF 159 could 
be tested for both its antimetastatic effect as well as its 
angiometamorphic effect.
When these approaches to therapy may be tried is a matter 
for speculation, partly because of the lack of suitable cases 
and partly because too many clinicians are too set in their 
ways. As Hellmann (1971) put it: "Naturally, untried drugs
must go to the end of the queue, so that when the patient is 
finally given the new drug, the conditions for its clinical 
trial are severe. With an increase in the number of compounds 
hopefully awaiting clinical trial, the organization of such 
trials should be considered carefully on a national level, if 
useful drugs are not to be discarded".
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Sum m ary
Profound modification o f the structu re  and arrangem ent 
o f the blood vessels has been shown in  tum ours afte r 
trea tm en t with ICRF 159. X -ray angiography, carbon 
black (Pelikan ink) labelling, and in trav ita l staining 
w ith lissam ine green were used to  dem onstrate the 
changes. A lteration o f the m orphology o f the blood
D epartm ent o f C ancer Chem otherapy, Im perial Cancer Research 
A m d, London WC2A 3PX
A. W. LE SERVE, B.sc,, I.C.R.F. Bursar 
K. HELLMAN, D.M., d.phil.. Head
vessels a t the edge o f a  tu m our m ay affect the escape 
o f m alignant cells and the ra te  o f blood flow (and thus 
the concentration o f an ticancer drugs) through the 
tum our.
Introduction
Treatment of the Lewis lung carcinoma (3LL) with ICRF 159 
( (± )- l ,  2-bis(3, 5-dioxopiperazin-l-yl) propane) inhibits the 
pulmonary métastasés resulting from bloodbome dissemination 
of 3LL cells (Hellmann and Burrage, 1969). The growth rate 
of the primary implant is, however, not significantly impeded by 
dosages required to produce this effect.
Histological examination of the possible mechanisms in­
205/72 C O P Y R IG H T  ©  1972. A l l  r i g h t s  o f  r e p r o d u c t i o n  o f  t h i s  r e p r i n t  a r e  r e s e r v e d  i n  a l l  c o u n t r i e s  o f  t h e  w o r l d
598
volved showed that the inhibition brought about by IC R F 159 
is probably due to normalization of the developing blood vessels 
at the invading margins of the primary tumours (Salsbury, 
Burrage, and Hellmann, 1970). In this region an ill-defined 
leash of poorly formed vascular sinusoids with frequent areas of 
haemorrhage is replaced, in treated tumours, by vessels of 
relatively normal appearance and character.
Such modification of the growth of tumour blood vessel 
structure appears to be a new type of drug action and one which 
could be of considerable importance, not only for prevention of 
métastasés but also in the treatment of primary and secondary 
tumours. It seemed desirable, therefore, to study this “angio- 
metamorphic” effect more closely, particularly by means of 
x-ray angiography.
M aterials and M ethods
Lewis Lung Carcinoma (3LL).—Tumours were inoculated 
subcutaneously into the flanks of inbred C57/B1 female mice 
weighing between 18 and 22 g. Aseptic precautions were 
observed. Experimental mice received ICRF 159 30 mg/kg 
suspended in 0 2 ml of carboxymethyl cellulose (0 5%) in 
isotonic saline (CMC) given daily intraperitoneally. Control 
mice received 0 2 ml of CMC alone intraperitoneally daily.
Walker 256 Carcinosarcoma.—In order to see differences in 
tumour vascular pattern more clearly the rat Walker tumour 
grown in the flanks of Sprague-Dawley rats (150-200 g) was 
studied. Experimental rats received ICRF 159 50 mg/kg 
suspended in 0 4 ml of CMC solution given intraperitoneally 
daily. Controls received 0 4 ml of CMC alone.
R adiographic P roced ure
Ninety-two C57/B1 mice with 3LL tumours were used for 
angiographic studies, of which 67 angiograms were of sufficiently 
high standard to be used for evaluation. Twenty Sprague- 
Dawley rats with Walker tumours were also used, of which 16 
angiograms were of a sufficiently high standard.
Various methods for the injection of contrast media into 
bromethol (Avertin) anaesthetized animals were tried, but 
retrograde intravenous injection proved most effective. Micro- 
paque (aqueous barium Lulphate about 1 oz/fl. oz (55g/50ml) ) 
was injected through a polyethylene catheter introduced into 
the inferior vena cava through the exposed right heart (Margulis, 
Carlsson, and McAlister, 1961).
Animals were placed in the supine position on a transparent 
tray with the x-r^y tube 18 in (46 cm) above. A'-ray film was 
placed on a shelf 18 in (46 cm) below and each radiograph was 
therefore twice life-size. Focal spot of the x-ray tube was 0 3 mm 
(Parish, Akester, and Gregg, 1964). Care was taken to give the 
contrast medium in the same volume and identical manner 
each time.
I N  V IV O  B L O O D  V E S S E L  L A B E L L IN G
Sixty-four C57/B1 mice with 3LL tumours and 18 rats with 
Walker tumours were used in these experiments. A colloidal 
suspension of carbon black (Pelikan biological ink Cll/1431a) 
diluted 1:4 with 1% gelatin in sterile saline was used (Oswald 
and Cater, 1969). This suspension contains about 10 mg of 
carbon per ml with an average particle size of 200 A; it is 
stabilized with 4 5% fish glue and contains 1-3% phenol as a 
preservative.
Mice (C57/B1) inoculated with 3LL tumour and treated with 
IC R F 159 or CMC received 012 ml of the diluted ink per 
20 g mouse into the lateral tail vein; 0 75 ml per 150 g Sprague- 
Dawley rat of the diluted ink was similarly injected intra­
venously into rats inoculated with the Walker carcinosarcoma 
treated with IC R F 159 or CMC. The animals were left for
one hour and then killed, the tumour and surrounding tissue 
were quickly removed, placed in 10'%, formol saline for 14 days, 
and then washed in distilled water for 24 hours before being 
transferred to 12-5''o gelatin at 37"C for 24 hours and then for 
another 24 hours into 25% gelatin also at 37 C. The blocks 
were embedded in 25% gelatin and stored in formol saline. 
Frozen sections cut at 25-35 nm were lightly stained with alum 
carmine and mounted in Highman’s mountant. At least eight 
frozen sections cut randomly from each tumour were examined. 
Random areas of the 3LL primary tumours were examined with 
the electron microscope in order to locate the position of the ink 
within the blood vessels.
The tissues were fixed in 4% glutaraldehyde in phosphate 
buffer for one hour and then post-fixed for a further hour in 
phosphate buffered osmic acid, and embedded in Araldite.
Sections (about 400 A) were cut on a Porter-Blum microtome 
equipped with a glass knife and stained with 25% uranyl acetate 
in methanol for 10 minutes, washed in methanol, and then further 
stained in lead citrate for four minutes and washed in distilled 
water. Sections were lightly coated with carbon and examined 
in the Siemens Elmiskop 1 electron microscope.
Some 3LL tumours were excised five minutes after intra­
venous injections of ink, and thick cryostat sections, stained with 
neutral red, were examined.
IN T R A V IT A L  S T A IN IN G  W I T H  L IS S A M IN E  G R E E N
Thirty-six C57/B1 mice inoculated with 3LL tumour and 
treated with ICRF 159 or CMC received 0 5-1 ml of a 2% 
lissamine green solution (Gurr) rapidly into the tail vein 
(Goldacre and Sylvén, 1962). Five millilitres of 2% lissamine 
green solution was similarly injected into rats inoculated with the 
Walker carcinosarcoma and treated with ICRF 159 or CMC. 
The animals were exsanguinated under ether five minutes 
after the injections of lissamine green. The tumours were 
bisected and examined.
R esu lts
A N G IO G R A P H Y  
3LL Tumour
Host Vessels.—No new vessels were seen to develop in response 
to the tumour, but host vessels draining the tumour were 
constantly dilated and some of these vessels became very
k,
FIG. 1—Venogram of a primary 3LL tumour 14 days 
after implantation and treated with CMC only. 
(X 14.)
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tortuous. Identical appearances were seen in animals where the 
tumour was treated with ICRF 159. At the border of the 
tumour angiographic appearances became very indistinct 
owing to vascular proliferation. I t  was not possible to distinguish 
whether this proliferation was in the host or the tumour tissues. 
Again the angiographic picture was the same for both control 
and treated tumours.
Tumour Vessels.—Control tumours showed large filling 
defects whose size and position varied from tumour to tumour. 
Such vascularization as there was appeared to be randomly 
arranged with vessels often ending abruptly (Fig. 1). This proved 
to be the constant picture in the control tumours. When the 
tumour was cut Micropaque flowed out from the cut surfaces. 
Tumours of the treated mice, however, showed numerous 
discrete blood vessels with some indication of a regular vascular 
arrangement (Fig. 2).
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FIG. 2—Venogram of a primary 3LL tumour 14 days 
after implantation and treated with ICRF 159 
(30 mg/kg intraperitoneally. Days 1-4, 7-11, and 14). 
( X  1-7.)
V.
Walker Tumour
Host Vessels.—Large new vessels did not develop in response to 
the tumour. On the other hand, three main host vessels—the 
lateral thoracic-cutaneous, the ilio-lumbar, and the inferior 
epigastric veins—were always considerably dilated, presumably 
to meet the demands of outflow from the tumour. Essentially 
the same picture was seen in ICRF 159 treated and control 
tumours. At the margins of the tumour, however, there was 
considerable proliferation of blood vessels in both treated and 
control tumours.
Tumour Vessels.—In the tumours themselves there was again 
a marked contrast between treated and controls. The control 
tumours showed signs of pooling of the Micropaque; there 
were avascular areas of varying size and position and commonly 
“corkscrewing” of dilated vessels. The vessels were also ran­
domly arranged and irregular, all of which is characteristic of 
tumour blood vessels (Fig. 3). The treated tumours, however, 
showed no signs of pooling and the blood vessels presented a 
more orderly arrangement. There was little evidence of any 
corkscrewing (Fig. 4).
I
FIG. 3—Venogram of a Walker carcinosarcoma 
seven days after implantation and treated daily 
with CMC. ( X  1-5.)
FIG. 4—Venogram o f  a Walker carcinosarcoma 
seven days afier implantation and treated daily 
with ICRF 159 (50 mg/kg intraperitoneally). 
( X  15.)
BLOOD VESSEL LABELLING
3LL Tumour
In  thick frozen sections of the primary treated tumours the ink 
was largely cleared, thus showing little labelling (Fig. 5), but in 
control tumours many vessels were clearly outlined (Fig. 6). 
With older and therefore more necrotic tumours the differences 
between the groups became much less apparent. Electron 
micrographs of control tumours showed the carbon trapped 
between basement membrane and an abnormal endothelium.
Walker Tumour
With this tumour treatment with ICRF 159 also reduced, but 
by no means abolished, the number of labelled vessels. Label­
ling in the treated tumours was found only near areas of haemor­
rhage and necrosis.
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FIG. 5— Frozen section of a primary 3LL tumour 14 days after implantation 
and treated with ICRF 159 (30 mg/kg intraperitoneally. Days 1-4, 7-11, 
and 14). Tumour excised one hour after intravenous injection of Pelikan ink. 
(Alum carmine. X 29.)
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FIG. 6—Frozen section of a primary 3LL tumour 14 days after implantation 
and treated with carboxjmethyl cellulose. Tumour excised one hour after 
intravenous injection o f Pelikan ink. (Alum carmine. X 29.)
INTRAVITAL STAINING
3LL Tumour
Gross observations revealed no differences between control and 
treated tumours at similar ages after tumour implantation. As 
the tumour increased in size the peripheral non-ischaemic zone 
became markedly reduced. There were no avascular, colourless 
areas in the tumour periphery. The youngest tumours (seven 
days, about 0 8 cm across) were usually coloured throughout, 
whereas in the oldest tumours (21 days, about 2 0 cm across) 
the peripheral vascularized zone was only a few millimetres 
thick.
Walker Tumour
Again gross observations revealed no differences between 
control and treated tumours. In  Walker tumours ranging from 
4 to 10 days old there was an increase in the size of the necrotic 
centre until in the largest tumours only a very thin peripheral 
vascularized zone remained.
Discussion
Willis (1952) pointed out that “the structure of the new- 
formed blood vessels in malignant tumours rarely approaches
that of normal veins or arteries, and the more rapidly growing the 
tumour, the more imperfect is the architecture of its vessels . . .  
in highly anaplastic growths, carcinomas as well as sarcomas, 
even the endothelium may be incomplete in places and the 
vascular channels lined in part by tumour cells.” Clearly such 
imperfections of vascular structure must favour dissemination of 
malignant cells. Willis’s statement applies with equal force to 
the Lewis lung carcinoma of the mouse (Salsbury et a/., 1970).
Previous observations indicated, however, that the structurally 
imperfect vascular architecture of the 3LL tumour can be 
improved by treatment with ICRF 159 (Salsbury et a/., 1970) 
and the present results lend considerable support to the assump­
tion that treatment with this drug normalizes 3LL vasculature 
functionally as well as morphologically. They also strengthen 
the conclusion that treatment with IC R F 159 prevents 
pulmonary métastasés because malignant cells do not line, nor 
do they penetrate, the normalized blood vessels and therefore 
cannot reach the blood stream. Consequently, they are unable to 
escape from the primary tumour.
Although it seems clear that as in other tumours the 3LL 
and the Walker have an outer shell of rapidly proliferating 
tumour cells permeated by a leash of imperfectly formed and 
randomly arranged vascular sinusoids, certain aspects of the 
angiograms call for comment.
In  3LL control tumours Micropaque diffuses into the wide 
spaces of the sinusoids in a “river-delta” effect, but because of 
the limitations of the resolution of the x-ray technique, radio­
opaque material cannot be demonstrated. The filling defects are 
therefore more apparent than real, and if the tumours are 
bisected Micropaque flows out from the cut surfaces. In treated 
tumours, however, the Micropaque is confined to the discrete 
vascular channels and consequently can be seen on the angio­
grams.
In Pelikan ink studies also, where tumours were excised five 
minutes after intravenous injection, the ink distributed itself 
throughout extravascular and intravascular spaces in the controls, 
but remained confined to the vessels in the treated tumours. 
The lissamine green injections provide further confirmation that 
the filling defects in the control venograms reflect only the 
insufficiently fine resolution of the angiograms.
The lissamine green injections also show that in both treated 
and control tumours vascularization is confined to an outer zone 
or cortex which encapsulates the tumours, but that the larger 
central and probably necrotic medulla appears not to be reached 
by the dye. I t can be assumed, therefore, that Micropaque is 
also confined to the peripheral zone and that the vessels seen 
on the angiograms are in the cortex. It seems probable that the 
blood flow rate in the wide diffuse spaces of the sinusoids in the 
“avascular” areas of the peripheral zone of the controls is very 
much lower than in the discrete vascular channels of the cortex of 
the treated tumours.
Recent histological examination of other tumours treated with 
ICRF 159 have shown that the blood vessel changes are not 
confined to the 3LL tumour (Salsbury, Burrage, and Hellmann, 
to be published). I t seems possible, therefore, that the drug 
affects the fundamental biochemical processes by which a tumour 
organizes a vascular supply to and into itself. These processes 
could well be similar in most tumours and have little or no 
parallel among normal tissues, thereby providing a selective 
target for cancer chemotherapy.
The abnormal character of tumour blood vessels and their 
functional normalization by ICRF 159 is well shown hy the 
Pelikan ink experiments. When Pelikan biological ink is injected 
intravenously it passes rapidly through normal vessels, but is 
trapped between the basement membrane and the endothelium 
if they are inflamed or otherwise damaged (Cater and Taylor, 
1966; Majno, Palade, and Schoefl, 1961). The considerable 
degree of vascular labelling in the control Walker and 3LL 
tumours is greatly diminished on treatment, but less so in the 
rapidly proliferating Walker tumour than in the more slowly 
growing 3LL. This,bears out Willis’s statement that the more 
rapidly growing the tumour, the more abnormal its vessels.
specific alterations of tumour blood vessels could have 
considerable consequences for the treatment of tumours. The 
use of vasoactive drugs to impair selectively the blood supply of 
tumours has been proposed on occasions—for example. Cater, 
Grigson, and Watkinson (1962) and Dayal and Goldacre 
(1969)—but the possibility that drugs might be used to alter 
blood vessel structure so as to prevent the escape of malignant 
cells from the primary tumours has not, so far as we are aware, 
been previously entertained or observed. This angiometa- 
morphic effect may, however, also mean that blood flow rates 
in treated tumours are higher and that consequently the avail­
ability of anticancer drugs might be increased. This considera­
tion may, in part, explain the greater effectiveness of other 
anticancer drugs when used in combination with ICRF 159 
(Hellmann and Burrage, 1970; Woodman, Venditti, Schepartz, 
and Kline, 1971). Although ICRF 159 is the first compound 
to be shown to exhibit an angiometamorphic effect, it is un­
likely to be unique in this respect, indeed other cytostatic 
bisdioxopiperazines are known to be active (Burrage, Hellmann, 
and Salsbury, 1970).
The antimetastatic effect of a number of well-known anti­
cancer agents has recently been investigated (Hellmann and 
Burrage, in preparation) but only cyclophosphamide has been 
studied in any detail. Cyclophosphamide inhibits 3LL meta­
stasis, though only to an extent proportional to its inhibition of 
the growth of the primary implant; it seems to have no angio­
metamorphic effect (Salsbury et al., 1970). 5-Fluorouracil, like 
ICRF 159, inhibited metastasis without overt effect on the 
primary implant. Prednisolone, on the other hand, had a 
pronounced inhibitory effect on the primary, but did not prevent 
metastasis. Whether these variations of response are related to 
changes in the tumour vasculature is being studied.
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The profound differences in the mode of action of anticancer 
drugs as exemplified by these results emphasizes once again 
that selective therapeutic activity among anticancer agents is 
more likely to be obtained by closer study of their pharmaco­
logical activities than by analysis of their non-specific inhibition 
of cell division.
We are grateful to Drs. D. B. Cater, R. J. Goldacre, and L. J, F. 
Youlten, for stimulating discussions and helpful advice, and to 
Miss L. Peachey for the electron microscopy. We are particularly 
indebted to Messrs. R. Akester and I. Edgar for their help and 
guidance with the angiography.
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Vascular changes in tumours after treatment with ICRF 159 
A. W. Le S e r v e  (introduced by K. H e l l m a n n )
Cancer Chemotherapy Department, Im perial Cancer Research Fund, London 
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M ice implanted subcutaneously with the Lewis lung (3LL) carcinoma regularly 
develop pulmonary m étastasés, which can be prevented by treatment with [ ( i ) -  
1,2-bis (3 ,5-dioxopiperazin-l-yl) propane] (IC RF 159) (Heilm an & Burrage, 1969). 
The poorly defined sinusoids which act as vascular channels in the periphery o f  con­
trol primary tumours are replaced by well formed discrete blood vessels in tumours 
treated with IC R F 159 (Burrage, H ellm ann & Salsbury, 1970). These changes in  the 
structure o f  the b lood vessels are probably responsible for preventing the escape o f  
malignant cells from  the primary tum our into the circulation.
The distribution and character o f  these 3LL blood vessels has now been further 
investigated by m eans o f  X-ray angiography and by a colloidal carbon technique 
which specifically outlines damaged and inflamed blood vessels (M ajno, Palade & 
Schoefl, 1961). A  com parison has also been made o f  the effects o f  IC R F 159 treatment 
o f  rats inoculated with the W alker carcinosarcoma.
A polythene catheter was inserted into the inferior vena cava through the exposed 
right heart o f  animals anaesthetized with Avertin. M icropaque was introduced slowly  
by retrograde injection and care was taken that introduction o f  contrast medium was 
performed In exactly the same way each time.
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Tor vciiogi’anis, the animals were placed ia a supine position on a transparent tray 
with tile X-ray tube 45 cm above them. The X-ray film was placed on another shelf 
45 cm below. Thus each radiograph was twice life size. Focal spot o f  the tube was 0-3 
mm. Venograms o f control tumours showed avascular areas, pooling o f  M icropaque 
and an irregular vascular network with many tortuous vessels. In treated tumours the 
venous pattern was discrete and well organized.
The colloidal suspension used was carbon black in the form o f dilute Pelikan b io­
logical ink Cl 1/1431a. Animals were left for I h after intravenous injections o f the 
dilute ink (0 12 mg/20 g mouse and 0 75 ml/150 g rat) after which the tumours were 
quickly removed and placed in 10% formol saline for 14 days. Frozen sections cut at 
25 -35 /im were lightly stained with M ayer’s Carmalum. Virtually no carbon labelling 
was found in the treated Lewis lung tumours, whereas controls showed vessels outlined  
with carbon in zones o f  growing tumour. The Walker tumours o f  control rats showed  
areas o f  carbon labelling both peripherally and centrally near necrotic and haemor- 
rhagic zones. Treatment with IC R F 159 reduced but did not abolish the labelling o f  
vessels.
I wish to thank A. R. Akester and I. Edgar for their invaluable assistance.
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Influence o f phenoharbitone on liver regeneration and microsomal N-demethylating 
activity in partially hepatectomized rats
A. R. Booms* and D . P o l l o c k  (introduced by J. S. G il l e s p ie )
Department o f  Pharmacology, University o f  Glasgow, Glasgow, W2
Normal rat liver is capable o f  remarkable adaptations to meet the functional 
demands upon it. For example, the low resting m itotic rate increases dramatically 
when part o f the liver is exiscd, the magnitude o f  the response being inversely 
related to the am ount o f  liver remaining. In addition, oxidative enzym ic activity in 
the intact liver can be greatly increased by drugs. For example, phenobarhitone 
increases the synthesis o f  the microsomal enzymes responsible for its metabolism. 
Each o f these processes involves the hepatocytc in considerable reorganization and 
in synthesizing new protein for such specialized structures as the m itotic spindle or 
the endoplasm ic reticulum. These two processes represent quite different types o f  
adaptation, since regeneration involves a less dilTerentiated activity (mitosis) than the 
synthesis o f  drug metabolizing enzymes. It is therefore o f  interest to know if both 
processes can occur simultaneously or whether one has priority.
This study investigated these possibilities in partially hepatectomized and sham  
operated male Wistar rats (250-350 g), pretrcated 12 h before surgery with pheno- 
barbitoue (80 m g/kg i.p.) and 1 h before death with mctaphasc inhibitor colchicine
